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INTRODUCTION 
 
The birth of a baby should always be a joyous time in the lives of its parents and  
family. There is nothing more satisfying in Obstetrics than to have a healthy mother  
and baby at the end of gestation. Unfortunately, this is not always the case, and when  
a baby is born too early this can cause immense financial and emotional trauma to the  
family. 
As we learn more and more about the morbidities and mortality associated with  
premature births, there is a special group of these infants coming to light, those born  
between 34+0/7 and 36+6/7 weeks. Now termed „late preterms,‟ these babies are at  
risk of short and long term consequences as a result of their premature birth. 
Research has been aimed to decrease the number of babies born at this gestation. One  
way is to prolong pregnancies complicated by preterm prelabour rupture of  
membranes (PPROM).  When these pregnancies are prolonged, there are risks. Does  
prolonging pregnancy increase infectious morbidity for the mother and baby? Is the  
risk of infectious morbidity preventing conservative management? 
If this question could be adequately addressed, then more and more late preterm births  
could be prevented, leading to more healthy, term babies. 
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AIMS AND OBJECTIVES OF THE STUDY 
 
 
Aim: 
 
To compare the fetal, neonatal and maternal outcomes in pregnant women presenting with  
pretermprelabour rupture of membranes with two types of treatment- namely - immediate  
delivery versus expectant management until 37 completed weeks of gestation. 
 
 
 
 
Objectives:  
 
1. To determine whether rates of neonatal sepsis were similar in babies born to 
 
womenpresenting with preterm prelabour rupture of membranes with two types of  
 
treatment- namely – immediate delivery versus expectant management until 37  
 
completed weeks of gestation. 
 
 
2. To determine whether these two approaches will cause significant differences in  
 
neonatal and maternal morbidities and mortality. 
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INTRODUCTION 
 
Preterm Prelabour Rupture of membranes (PPROM) is described as rupture of  
 
membranes before the onset of labour from the gestational age of  20 to <37 weeks  
 
(American College of Obstetricians and Gynecologists, 2013). 
 
Globally, PPROM occurs in 3 to 4.5% of all pregnancies(1).  The incidence of  
 
PPROM in Indian studies has been shown to be about 7 – 8%. (2) These account for  
 
nearly 30 – 40% of all preterm deliveries, and consequently a large proportion of  
 
neonatal as wellas maternal morbidity.  
 
According to timing of birth, preterm births can be divided into  
 
 Extremely preterm : Less than 28 weeks 
 Very preterm : 28 to <32 weeks 
 Moderate preterm : 32 to <34 weeks 
 Late Preterm : 34 to 36 + 6 weeks of gestation (3) . 
 
It has recently been noticed that those infants born between 34+0/7 and 36+6/7 weeks  
 
have characteristic morbidities and mortalities. It was also observed that those born  
 
between 37+0/7 and 38+6/7 weeks of gestation experience more morbidities than  
 
those born after 39 completed weeks to 40+6/7 weeks. This latter group has been  
 
found to have the lowest infant mortality than babies born in any other period in  
 
human gestation (4). 
 
 
Much of the morbidity/ mortality associated with PPROM are due to the premature  
 
nature of the baby, and include those affecting the Respiratory System  
 
(eg.Respiratory Distress Syndrome), Gastrointestinal system (eg. Necrotising  
 
Enterocolitis),  Immunological,  Renal,  Cardiovascular,  Central Nervous System.   
 
The incidence of these complications decline the nearer to term that the PPROM  
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occurs.  Hence there may be considerable health benefits to the fetus in continuing a  
 
pregnancy after PPROM in the late second and third trimesters. There is emerging  
 
evidence that this holds true for late preterm babies as well. 
 
However, there are also problems inherent to PPROM, such as cord prolapse,  
 
ascending infection and abruption placentae. Chorioamnionitis is of particular 
 
mention, as this can translate to Fetal Inflammatory Response Syndrome (FIRS) and  
 
its effects such as periventricular leucomalacia and cerebral palsy are independent of  
 
the ill effects of prematurity (8). However most studies include early preterm babies, 
 
or those with very low birth weights and it might be difficult to extrapolate the results  
 
to our intended study population as the incidence of  cerebral palsy in near term/ term  
 
infants is lower (maximum reported incidences of 1.9% in the chorioamnionitis 
 
group)(7). Mothers affected by chorioamnionitis are also at a greater risk of sepsis and  
 
its ill effects. 
 
Hence the ultimate goal of management should be to minimise the immaturity of the  
 
fetus, while avoiding harmful effects of remaining in utero. 
 
A recent Cochrane review  (5)was undertaken to assess the effect of planned early  
 
birth versus expectant management for women with preterm prelabour rupture of the  
 
membranes between 24 and 37 weeks‟ gestation for fetal, infant and maternal well  
 
being. There was no significant difference in neonatal sepsis between those  
 
babies delivered early and those managed expectantly (risk ratio (RR) 1.33, 95%  
 
confidence interval (CI) 0.72 to 2.47.  
 
The incidence of respiratory distress was also not significantly increased in the  
 
Induction of Labour (IoL) group, neither was there a difference in overall neonatal or  
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intrauterine mortality.  
 
There was, however, a non-significant trend towards more neonatal deaths in  
 
pregnancies which underwent early IoL and an increase in intrauterine deaths in those  
 
who received expectant management. There was one trial (Mercer 1993) which  
 
reported on suspected early onset neonatal sepsis. It was found that there was a  
 
significant decrease in sepsis associated with early delivery, as well as a decreased  
 
need for neonatal antibiotics. 
 
Five studies (Cox 1995; Garite 1981; Iams 1985; Mercer 1993; Naef 1998) reported  
 
the number of women who developed chorioamnionitis. Overall, there was no  
 
significant difference in the women who developed chorioamnionitis in the early  
 
delivery group compared with the expectant management group (RR 0.44, 95% CI  
 
0.17 to 1.14; I2 = 56%; 575 women). There was, however, substantial heterogeneity  
 
between the trials in assessing chorioamnionitis (demonstrated by an I2 of 56%.) At  
 
the time of the Cochrane review, there was only one study which included the group  
 
of our interest, 34 – 37 weeks gestational age (Naef 1998) , therefore the review   
 
included only these 120 women. Early delivery resulted in a reduction in  
 
chorioamnionitis (RR 0.11, 95% CI 0.01 to 0.84), with no significant increase in  
 
caesarean section (RR 1.47, 0.34, 6.30). It was concluded that there was insufficient  
 
evidence on the clinical benefits and harms for women and their babies of immediate  
 
delivery compared with expectant management for women with PPROM to make  
 
recommendations with which to guide clinical practice. The need for further,  
 
methodologically sound, adequately powered clinical trials to guide the management  
 
of PPROM was stressed upon. 
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Hence, given the myriad problems that are associated with the late preterm, it is  
 
prudent to avoid delivery at this gestation.  However, on the other hand, with  
 
expectant management there is concern about the risk of ascending infection. 
 
The current management of PPROM is based on the gestational age at which PPROM  
 
hasoccured. There is consensus on the management of pregnancies upto 34 weeks  
 
complicated by PPROM, with most major Obstetric societies (American Congress of  
 
Obstetrics and Gynaecology 2013, Royal College of Obstetricians and Gynaecology –  
 
Greentop Guideline Number 44 (6) ) advocating expectant management till 34  
 
completed weeks, followed by planned early delivery. 
 
For example the American Congress of Obstetrics and Gynaecology (2013)  
 
(7)recommended that all PPROM cases beyond 34 weeks undergo immediate  
 
delivery.  
 
Prolonging pregnancies upto 37 weeks may have a significant impact on decreasing  
 
composite neonatal morbidity, without increasing rates of neonatal sepsis. With  
 
careful maternal fetal monitoring and timely intervention, complications such as  
 
chorioamnionitis may be avoidable. This is the clinical question hoped to be answered  
 
in this study. 
 
 
 
 
 
Statistics 
 
 
United States of America 
 
In the US, preterm births showed an increase from 10.6 in 1990 to 12.8% of all live  
 
births in 2006, this was an all time high. This rise was largely attributable to a rise in  
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preterm births, as newer modalities of diagnosis and better obstetric care lead to  
 
diagnosis of fetal, placental and maternal complications that led to  medically  
 
indicated late preterm births. The late preterm births rose from 7.3 to 9.1 percent of all 
 
live births in 2006,  accounting for >250,000 births per year. Preterm birth rates have  
 
since fallen, comprising 9.6% of all births in 2014-2015. There was a decline in late  
 
preterm births from 9% in 2007 to 6.8% in 2015, indicating real progress in efforts to  
 
prevent late preterm births.(8) However, from 2014 to 2015, the US preterm birth rate  
 
rose from 9.57% to 9.62%. This increase was mainly in the late preterm (34 to 36  
 
week) group, in whom birth rates increase from 6.82% to 6.87% (9) 
 
Petrini et al (10)found that infants born from 34 to 36 weeks (late preterm), account 
for  
 
about 70% of all preterm births.  35% of these births were due to PPROM.  
 
 
 
 
India 
 
In India,there has been a significant decrease in the number of neonatal deaths - from  
1.35 million in 1990,  to around 0.76 million in 2012. (11)The causes of neonatal  
deaths in India are as follows: 
 
(Source: Liu et al, Lancet 2012 (12) ) 
Causes of Neonatal deaths in India
Birth Asphyxia 20%
Preterm 35%
Other 3%
Malformations 9%
Diarrhoea 2%
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Worldwide Statistics 
There are not many worldwide statistics for preterm labour and PPROM. The Royal  
College of Obstetrics and Gynaecology cites an incidence of PPROM of 2%, which  
accounts for 40% of the incidence of preterm deliveries (13). One Nigerian study  
quotes an incidence of 3.3%, with a perinatal mortality of 7%(14). 
 
Race and Socioeconomic status 
Savitz et al (15)demonstrated a  higher incidence of PPROM in the black population  
(5.1% to 12.5%), which contrasted with an incidence of 1.5 – 2.2% in the  
corresponding white comparision groups. However, other studies such as the Preterm  
Prediction Study (16) have not confirmed this increased risk in black women to be  
statistically significant. 
Miller et al (17) did not find a statistical difference in the incidence of PPROM  
between various socioeconomic groups. 
 
Incidence of Chorioamnionitis 
Chorioamnionitis is a common complication with PPROM.The incidence of  
 
chorioamnionitiswith PPROM has been studied in gestations less than 34 weeks and  
 
has been found to be between 19% and 58.6% (18,19).  It was found to be higher with  
 
decreasing gestational age. 
 
One particular review found the following incidence according to gestation at  
 
delivery: 
 
<27 weeks – 41% 
28 to 36 weeks – 15% 
Term – 2% (20). 
 
 
21 
 
PATHOGENESIS OF PPROM 
 
The pathogenesis behind PPROM is of uncertain significance. 
 
1. Cell death, and the breakdown of Collagen 
 
 PPROM may be related to increased levels of certain proteases in the amnionic fluid/   
 
membranes, or increased apoptosis of cell membrane components.The tensile strength  
 
of the amnionicmembranes has been attributed to extracellular matrix of the amnion  
 
as well as type I and III interstitial amnionic collagen. These are produced in  
 
mesenchymal cells (21). Hence, the degradation of collagen in the amnion has been an  
 
area of research in elucidating the pathogenesis of PPROM. 
 
Matrix Metallo-Proteinases (MMPs) are usually implicated in the degradation of  
 
collagen. It has been found that certain types of MMPs, namely MMP-1, MMP-2,  
 
MMP-3, MMP-9, are increased in the amnionic fluid of pregnancies with PPROM.  
 
Furthermore, inhibitors of MMPs, namely Tissue Inhibitor of Matrix  
 
MetalloProteinases (TIMPs), are found to be decreased in the amnionic fluid in such  
 
pregnancies (22,23) . 
 
A more recent study done in 2013 by Mogami et al (24) provides a mechanism  
 
wherein bacterial endotoxin or TNF causes release of fFN (fetalfibronectin) from  
 
amnionic epithelial cells. This fFN then binds to Toll-like receptor 4 which is present  
 
in amnionic mesenchymal cells which causes activation of signalling cascades. This  
 
causes raised Prostaglandin E2 synthesis and increases activity of MMP 1,2 and 9.  
 
PG-E2 incites uterine contractions and causes cervical ripening, while the MMPs  
 
allow for collagen to breakdown in the amnion thereby rupturing membranes. 
 
These pregnancies exhibit higher rates of apoptosis markers and a greater degree in  
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cell death than that of term amnions. In vitro studies have shown that this apoptosis is  
 
most likely regulated by TNF, IL-1 and bacterial endotoxin (25). 
 
Proteins involved in the synthesis and maturation of cross-linked collagen, as well as  
 
the matrix proteins that are involved in the binding of collagen and promotion of  
 
tensile strength seem to be altered in pregnancies with PPROM (26) . 
 
All these observations give strength to the theory that PPROM may result from altered  
 
collagen assembly, degradation of collagen and cell death. These could lead to a  
 
weakened amnion and early  rupture of  membranes. 
. 
2. Infection 
 
There is much evidence pointing to infection as a cause of PPROM. A review of 1500  
 
women from 18 studies found that in one third of cases of PPROM, bacteria was  
 
isolated from the amnionic fluid (27). 
 
WHY WORRY ABOUT THE LATE PRETERM NEONATE? 
The rise in overall preterm births is largely attributable to delivery of late preterm 
babies. These babies, though sometimes the same size and weight as term neonates,  
have been found to have a higher morbidity and  mortality.  
This is attributed to their relative immaturity, both metabolically and physiologically. 
The problems with late preterm are as follows: 
1. During Hospitalisation at birth 
 Hypothermia 
 Hypoglycemia 
 Respiratory morbidity 
 Apnea 
 Hyperbilirubinemia 
 Feeding difficulties 
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2. Complications following Post Birth Discharge 
 
3. Long term morbidity 
 Neurodevelopmental consequences 
 Others- Failure to thrive, Respiratory outcome 
 
4. Mortality 
 
1. Morbidity during  Hospitalisation at Birth 
Petrini et al (10)found that infants born from 34 to 36 weeks (late preterm),  
 
account for about 70% of all preterm births.  35% of these births were due to PPROM.  
 
Neonatal mortality rates, as well as morbidity indices were significantly increased in  
 
each late preterm week compared with those at 39 weeks as the referent. Specifically,  
 
the frequency of respiratory morbidity decreased by approximately 50 percent per  
 
week from 34 to 37 completed weeks.   
 
A retrospective study by Wang et al studied 90 late preterm and 95 term neonates.  
 
Although both had similar length of hospital stays, it was found that late preterm  
 
infants had significantly more medical issues than term  infants. They had higher rates  
 
of respiratory morbidity, temperature instability, evaluation for sepsis, jaundice  
and incurred higher hospital costs than their term counterparts. Apnea and  
bradycardia, though rare, were found only in the late preterm group. (28) 
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(Reproduced from Wang et al, 2004) 
 
2. Post Birth Discharge 
 
Hwang et al demonstrated that late preterm infants were less likely to be discharged  
 
early than term infants(29). Cost of hospital care and rehospitalisation rates have also  
 
been shown to be higher for these babies. McLaurin et al studied 33,745 term babies  
 
and 1683 late preterm babies. On average, term babies were hospitalised for 2.2 days,  
 
incurring average costs of $2061. On the other hand late preterms tend to be  
 
hospitalised for longer, 8.8 days on average, with an average cost of $26,054.  First  
 
year costs were also 3 times higher on average for late preterms, $12,247 as  
 
compared to $4069 for term infants. Higher rates of rehospitalisation were recorded  
 
for late pretems than term infants (15.2% vs 7.9%). There were a subset of late  
 
preterm infants with late discharge from hospital at birth that had the highest health  
 
care costs and rehospitalisation rates. 
 
This not only shows that late preterm have higher morbidity and health care costs than  
 
term infants, but that this difference persists through the first year of life.(30) 
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3. Long term Morbidity 
 
Long term morbidity will be studied under the following headings  
 
 Neurodevelopmental consequences 
 Failure to thrive 
 Long term respiratory morbidity 
 
 
A. Neurodevelopmental consequences: 
 
It has been coming to light that late preterm babies may be at higher risk of more  
 
subtle neurological issues, such as inferior performances academically or behavioural  
 
issues(31).  
 
 
Pathogenesis of neurological injury 
 
The possible mechanisms of neurological injury in these babies may be as follows: 
 
1. Prematurity, and complete neurological maturation taking place outside the 
uterine mileu.  
2. Morbidity that is a consequence of late preterm delivery 
3. The underlying primary cause of the preterm labour 
 
The last half of pregnancy (including 34 to 36+6 weeks) is considered critical for  
 
brain development, with rapid/ dramatic changes in structural, molecular and  
 
neurochemical parameters. Brain weight at 34 weeks is just 65% of that of the term  
 
brain. Gyral and sulcal formation is incomplete at this stage.  Twenty five percent of  
 
cerebral development occurs between 34 and 40 weeks, and cortical volume increases  
 
by 50% during this time period. Because the relative proportion of both gray and  
 
myelinated white matter to total brain volume increases so exponentially during this  
 
time, the period between 34 and 40 weeks gestation is critical. The late preterm brain  
 
is more vulnerable to free radical mediated injury and glutamate induced injury. This  
 
is due to the susceptible nature of the immature oligodendrocytes, as well as the  
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immaturity of the antioxidant enzymes that regulate stress.  
 
Dendritic arborisation and synaptogenesis are still occurring and therefore incomplete  
 
in the late preterm brain. This is more pronounced in the very premature brain (31). 
 
 
Possible long term neurodevelopmental consequences 
 
The neurodevelopmental consequences can be myriad. There have been significant  
 
associations between late preterm births and the following: 
 
 Cerebral palsy 
 
Petrini et al(10) found that children born late preterm were more than 3 times as likely  
 
to be diagnosed with cerebral palsy than those born at term (hazard ratio, 3.39; 95%  
 
CI, 2.54-4.52) 
 
 Developmental delay/ Mental retardation 
 
A study done in 2009  by Morse et al (32)compared outcomes in prekindergarten and  
 
kindergartenbetweenhealthy late preterm and  healthy term infants. Investigators 
 
found a 36% higher risk for developmental delay or disability for late  
 
preterm infants compared with term infants. These late preterm infants had a 19%  
 
higher risk of being suspended from kindergarten. Risk of retention in kindergarten  
 
was also 19% higher for late preterm infants. The assessment of not being ready to  
 
start school was only borderline significant.This study concluded that healthy preterm  
 
infants are at a higher risk for school- related problems and developmental delay and  
 
school related problems up to the first 5 years of life. 
 
Petrini et al (10)found that the lower the gestational age, the higherthe incidence of  
 
developmental delay/ mental retardation. This was found true even for thosebabies 
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born between 34 and 36 weeks. For these children, an association was found with  
 
developmental delay and mental retardation (hazard ratio, 1.25; 95% CI,m1.01-1.54). 
 
 
On the contrary, a study from the National Institute of Child Health and Development  
 
Study of Early Child Care and Youth Development (33)showed no significant  
 
difference. This study followed a total of 1298 children, 53 of which were healthy late  
 
preterms, the remaining being healthy term babies. These were followed from birth  
 
till age 15.  Standard outcomes such as social skills, cognition, behavioural and  
 
emotional outcomes were studied. No consistent or significant difference was found  
 
between the two, indicating that healthy late preterms may not be at a significant  
 
disadvantage than their term counterparts. 
 
 
B. Failure To Thrive 
 
Goyal et al (34)studied 7,866 infants upto 18 months of life. The study population  
 
included late preterm and term infants and the main outcome measure at 6,12 and 18  
 
months was a weight-for-age z score of 2 or less. It was found that late preterms had  
 
higher adjusted odds ratios of weight-for-age z scores of 2 or less at 6 and 12 months  
 
of age. However, at 18 months, there was no significant difference. 
 
C. Long term Respiratory Morbidity  
 
Data are inconsistent, and it is still uncertain whether late preterm babies suffer long  
 
term respiratory morbidity compared to term infants. 
 
A Swedish study (35)using a national cohort of 622,616 infants were followed from  
 
ages 25 through 35, and it was determined whether medications for asthma were  
 
prescribed between 2005 and 2007. They found that very early preterms (born at 23  
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to 27 weeks of gestation) were 2.4 times more likely to have been prescribed these  
 
medications as adults. However, no association was found between later preterms 
 
(those born from 28 to 36 weeks).Abe et al(36) showed a modest association  
 
between late preterms and physician diagnosed asthma, but this was not found to be  
 
statistically significant. 
 
 
 
4. Mortality 
 
Tomashek et al(37)used US period linked birth/infant death files from 1995 – 2002,  
 
and compared cause- specific and overall early/ late neonatal/ post neonatal and infant  
 
mortality rates between singleton infants, both those born late preterm and term. There  
 
was a significant decline in mortality rates for both late preterm and term neonates.  
 
However, despite this decline, infant mortality rates in the year 2002 were three times  
 
higher for late preterm as compared to term infants(7.9 versus 2.4 deaths per 1000  
 
live births.  These late preterm infants were four times more likely to die of newborn 
 
bacterial sepsis, congenital malformations and complications with regard to placenta,  
 
cord and membranes. 
 
Even early, late and postneonatal mortality rates were six, three and two times higher  
 
in late preterms respectively. 
 
Authors concluded that late preterm infants have higher mortality rates than their term  
 
counterparts all through infancy. These findings again bring to light the need to  
 
prevent late preterm births as far as possible. 
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INCIDENCE OF PPROM 
 
As mentioned before, most western literature quotes PPROM to occur in 1 – 5% of  
 
pregnancies.  As stated, the incidence of PPROM in Indian studies has been shown to  
 
be about 7 – 8%(2).  It is the most common factor identifiable with preterm labour. 
 
 
CLINICAL COURSE 
 
Most studies have studied the clinical course of PPROM before 34 weeks. Most of  
 
these cases deliver within one week of membrane rupture. The period of latency was  
 
more than 48 hours in about 73.4% of cases(38). Women who delivered earlier than 
 
48 hours tended to have a greater cervical dilatation and were more likely to be 
 
nulliparous. Average period of latency was 0 – 59 days, and had an inverse  
 
relationship with gestational age at admission (P< 0.001)(38). Spontaneous resealing  
 
of membranes has been found to be very rare, except in cases of iatrogenic PPROM  
 
due to amniocentesis. These women tend to have a more favourable clinical course  
 
and outcome and should always be managed conservatively(39). 
 
 
 
PREDISPOSING/ RISK FACTORS FOR PPROM 
 
Maternal genetic, physiological and environmental factors most likely contribute, but  
 
in most cases no risk factors are found. 
 
1. Prior History of PPROM 
 
Women with prior PPROM are at risk of PPROM / preterm birth without PPROM in  
 
subsequent pregnancies.  A large prospective study, the Preterm Prediction Study  
 
conducted by the National Institute of Child Health and Human Development  
 
(NICHD) Maternal-Fetal Medicine Units (MFMU) Network, found that women with  
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history of PPROM had a 13.5% rate of PPROM in subsequent pregnancies. In those  
 
with no such history, the rate was only 4.1% (RR 3.3, 95% CI 2.1-5.2) (16). Asratet 
 
al reported a much higher recurrence rate of 32.2% in their study (40). 
 
2. Genital Tract Infection 
 
Infection in PPROM: Cause or Effect? There are very good reasons to presume that  
 
infection may be the cause of PPROM, but substantial evidence has yet to come to  
 
light. Women with genital tract infections, specially bacterial vaginosis, have a higher  
 
incidence of PPROM than uninfected women. Also women with PPROM have  
 
significantly higher rates of amniotic fluid cultures being positive, as well as evidence  
 
of histologic chorioamnionitis than women who deliver prematurely without history  
 
of PPROM (41) . 
 
These organisms may produce substances that incite membrane degradation, as well  
 
as induce host inflammatory responses, both of which could lead to premature rupture  
 
of membranes and preterm labour. 
 
Predisposing factors for ascending infection of the genital tract may be as follows: 
 
 Prolonged membrane rupture 
 Prolonged labour 
 Multiple digital vaginal examinations 
 Nulliparity 
 Internal fetal/ uterine monitoring 
 Presence of genital tract pathogens 
 Tobacco/ alcohol use   (42). 
 
 
3. Antepartum bleeding 
 
First trimester vaginal bleeding has been found to have a small, but significant  
 
increase in risk for PPROM (43). 
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4. Cigarette Smoking 
 
These individuals have a 2 to4 fold increased risk of PPROM compared to non 
 
smokers(44,45). 
 
 
DIAGNOSIS OF PPROM 
 
 
History: Most women will complain of fluid leaking from the vagina. However, some  
 
may have inconsistent historical findings, such as leakage of small amounts of fluid,  
 
or a feeling of wetness on the perineum.  Williams Obstetrics describes a history of a  
 
continuous stream or gush of fluid from the vagina. 
 
 
Physical Examination: A simple local examination, asking the patient to cough or  
 
performvasalva may aid in diagnosis. A sterile speculum examination to grossly  
 
visualiseamnionic fluid pooled in the vagina, clear fluid draining from the cervix or  
 
both is done (Williams Obstetrics, 24
th
 Edition).  
 
 
CONFIRMATION OF DIAGNOSIS 
 
Ferning: A swab is taken from the posterior fornix and swabbed onto a glass slide.  
 
This is allowed to dry and then observed under a microscope for about ten minutes.   
 
Amniotic fluid produces a ferning pattern, whereas dried cervical mucus will produce  
 
a thick, wide arborisation. 
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Ferning pattern due to amniotic fluid 
 
(Source: Beckmann CRB, Ling FW, Smith RP, et al. Obstetrics and Gynecology, 5th 
Edition. Philadelphia: Lippincott Williams & Wilkins, 2006.) 
 
 
False positive can be caused by well estrogenised cervical mucus.  False Negatives  
 
can be obtained if inadequate amniotic fluid is collected, or there is contamination  
 
with vaginal secretions or blood. 
 
Ferning seen with estrogenised cervical mucus 
 
(Source: Scott JR. Danforth's Obstetrics and Gynecology, 6th Edition. Philadelphia: 
J.B. Lippincott, 1990.) 
 
 
 
 
Ultrasound Examination: This reveals a decreased amniotic fluid index in 50-70% of  
 
pregnancies (46). 
 
Laboratory Tests: When history is not forthcoming or uncertain, then one might need  
 
to use laboratory tests to confirm the diagnosis of PPROM. 
 
1. Nitrazine test: pH of the amniotic fluid (7 to 7.3) is higher than that of the  
 
vagina (3.8 to 4.2). Thus diagnosis can be inferred by testing the pH of the vaginal  
 
fluid (47). 
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pH testing using Nitrazine test 
 
(A) Normal, (B) Bacterial vaginosis, (C) Pregnant woman with premature rupture of 
membranes. 
 
2. Amniosense: This is an absorbent pad that can be worn as to detect ruptured  
 
membranes. Studies show that it is a useful test, negative results can proved assurance  
 
of intact membranes and it might helpprevent unnecessary speculum examinations 
(48). 
 
3. Commercial Tests 
 
Actim PROM: This test is used in the CMC labour room. It is useful in cases where  
 
diagnosis is in doubt. It identifies insulin-like growth factor binding protein 1 
 
(IGFBP-1), also known as placental protein 12 (PP12). 
 
This is a protein which is produced by decidual and placenta cells. It is present in very  
 
high concentration inamniotic fluid. 
 
A positive test is denoted by the presence of two parallel blue lines. It is unaffected by  
 
presence of semen, vaginal fluids, small volumes of blood or urine in the vagina.  
 
It has a sensitivity of 95 to 100 percent, specificity of 93 to 98 percent, and positive  
 
predictive value is nearly 98 percent(49) . 
 
 
ROM Plus (Alpha Fetal Protein and Placental protein 12/insulin-like growth factor  
 
binding protein):  This test detects both these protein markers in amniotic fluid. It is a  
 
mono/polyclonal antibody test. A study comparing the value of this test to Speculum  
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examination+ Nitrazine + Fern tests showed that this test has a high sensitivity  
 
(99 % vs 85%) but a lower specificity (91 vs 98%) (50) . 
 
 
AmniSure (Placental alpha microglobulin-1 protein):  This test, available as a kit, is a  
 
rapid test which uses immunochromatography methods to detect placental alpha  
 
microglobulin 1 in vaginal fluid.  
 
It is not affected by semen or minute amounts of blood. Sensitivity is about 94 to  
 
98.9%, with a specificity of 87.5 to 100%).The positive predictive value is reported to  
 
be100%, and negative predictive value 99.1% (51). 
These tests are relatively expensive, and use is limited to cases where physical  
 
examination, Nitrazine and fern tests are inconclusive. 
 
 
FetalFibronectin: A negative test is strongly suggestive that membranes are intact.  
 
However, a positive test is an indication that there is disruption between chorion and  
 
amnion, which may be the case with intact membranes (52). 
 
 
Alpha Fetoprotein:Alpha Fetoprotein is present in high proportions in amnionitic 
 
fluid. It is present in other bodily secretions, but to a lesser degree. Its presence in the  
 
vagina at a level > 3.88 ng/mL is suggested for a diagnosis of rupture of membranes.  
 
It is a much more cost effective test, however can produce false positives with the  
 
presence of blood in the vagina (53). 
 
 
DIFFERENTIAL DIAGNOSIS 
 
In cases with uncertain history/ clinical findings, one should consider other diagnoses.  
 
These could be urinary incontinence, excessive vaginal secretions or perspiration. 
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COMPLICATIONS OF PPROM  
 
 
Pregnancy complications with PPROM 
 
Pregnancy complication 
   
Potential consequences for 
offspring 
Potential maternal 
consequences 
Intrauterine infection Neonatal sepsis 
Cerebral palsy, other 
neurodevelopmental 
abnormalities 
 
Postpartum endometritis 
 
Oligohydramnios Umbilical cord compression, 
Fetal Asphyxia 
 
Cesarean delivery 
Fetalmalpresentation Cord Prolapse - asphyxia Cesarean delivery 
 
Abruptio placentae Asphyxia Cesarean delivery, 
Coagulopathy 
 
Preterm birth Morbidity of prematurity, 
including patent 
ductusarteriosus , 
intraventricularhemorrhage, 
respiratory abnormalities, 
necrotizing enterocolitis, 
retinopathy of prematurity,  
Failed induction - Cesarean 
delivery 
 
 
(Reproduced from UptoDate.com) 
 
 
1. Risks to Neonate 
 
The fetus and neonate are at risk for complications arising from PPROM. These can  
 
be 
A. Prematurity related morbidity 
B. Exposure to intramniotic infection 
C. Cord prolapse 
D. Abruptio Placentae and fetal distress 
E. Malpresentations 
F. Early PPROM and severe oligohydramnios can lead to pulmonary hypoplasia,  
orthopaedic abnormalities and facial deformation. 
 
2. Risks to Mother 
 
A. Infections: Chorioamnionitis,  Endometritis, Sepsis 
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B. Abruptio Placentae 
C. Higher rates of Caesarean section 
 
 
 
COMPLICATIONS OF PPROM 
 
A. Exposure to Intramniotic Infection  
 
Intramniotic infection (IAI) is the infection of the amniotic fluid, placenta, membranes  
 
and/or decidua. 
 
Pathogenesis: It is usually caused by ascending infection, i.e., organisims from the  
 
cervicovaginal flora when there has been a breach in the amniotic membranes. Other  
 
rare causes include transplacental migration (eg. Listeria monocytogenes) , and  
 
iatrogenic causes eg. Inoculation during amniocentesis, fetal blood sampling,  
 
chorionic villus sampling or fetal surgeries. 
 
Incidence: Common in labour at term, the frequency is highest in preterm deliveries. 
 
The incidence with PPROM has been studied in gestations less than 34 weeks and has  
 
been found to be between 19% and 58.6%(18,19). It was found to be higher with  
 
decreasing gestational age. 
 
Risk Factors for Chorioamnionitis 
 
Prolonged membrane rupture and prolonged labour are two of the most important risk  
 
factors. It is relevant to our study as this is the main worry with expectant  
 
management of PPROM. There is a breach of membranes, and every risk of  
 
chorioamnionitis. Hence, a careful evaluation to rule out clinical/ subclinical  
 
chorioamnionitis was of utmost importance in our study. 
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Confirmation of clinical suspicion of infection (chorioamnionitis) 
 
Usually in the background of ruptured membranes/ prolonged labour. Can occur with  
 
intact membranes. 
 
 
Common clinical features in chorioamnionitis 
 
Clinical features Frequency in Chorioamnionitis (%) 
 
Fever 95-100 
Maternal Tachycardia 50-80 
Fetal Tachycardia 40-70 
Uterine tenderness/ foul, purulent 
amniotic fluid 
4-25 
 
(Source: Tita et al, ClinPerinatol. 2010 Jun; 37(2): 339–354) (54) 
 
 
Maternal fever >100.4 degrees F persisting for greater than one hour, or any fever  
 
more than 101 degrees in pregnancy needs to be evaluated. Fever is a prerequisite for  
 
diagnosis.(54) 
 
Laboratory Tests 
 
1. Leucocytosis  
 
A total WBC count of >12,000 or >15,000/mm3, or on differential count a shift to  
 
the left/ bandemia>9% is present in 70-90% cases of clinical chorioamnionitis.  
 
Leucocytosis in the  absence of clinical signs has been found to be of limited value  
 
as it can be caused by other factors such as prolonged labour and steroid use. 
 
2. C- Reactive Protein 
 
CRP is an acute phase reactant that is elevated in the presence of inflammation. A  
 
review done by Van de Laar et al in 2009 sought to determine the accuracy of CRP  
 
in predicting chorioamnionitis and neonatal infection in women with PPROM.The 
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authors included studies which measures maternal CRP levels in women with  
 
PPROM varying from 20 to 36+6/7 weeks. 
 
 
Outcomes studied were  
 
 Neonatal sepsis (positive blood culture/ clinical signs of 
infection) 
 Suspicion of clinical chorioamnionitis 
 Histological chorioamnionitis 
 
Assay used to measure CRP was nephelometry, one study used immunoassay.  
 
Diagnostic thresholdsused in the studies ranging from >12 mg/L to 40mg/L, and  
 
interval between the determination of CRPranged from 12 to 72 hours. 
 
Results: Five cohort studies with 372 evaluable participants were included.  Most  
 
studies did not meet the criteria for neonatal sepsis. 
 
A SROC (summary receiver operating characteristic) was constructed for histological  
 
chorioamnionitis. However, a reliable SROC could not be estimated for clinical  
 
chorioamnionitis due to significant heterogeneityamong studies reporting clinical  
 
chorioamnionitis. 
 
Clinical Chorioamnionitis: Prevalence was 25.8% (18 to 50%). Sensitivity of CRP for  
 
clinicalchorioamnionitis at a diagnostic threshold of >20mg/L was 55%, and for  
 
>12.5 mg/L was 100%. Specificity at a diagnostic threshold of >20mg/L ranged from  
 
55 to 98%. 
 
Histological Chorioamnionitis:Prevalence was 54.6% (21 to 63%). Sensitivity of  
 
CRP at a diagnostic threshold of >40mg/L was 37%, and at a threshold of 12.5mg/L  
 
was 88%. Specificity was a 100% at a diagnostic threshold of >40mg/L, and 68% at a  
 
threshold of >20mg/L. 
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Conclusion: CRP is moderately predictive of histological chorioamnionitis. The  
 
studies that reported clinical chorioamnionitis had too much heterogeneity to pool  
 
data. No data was available on CRP as a predictor of neonatal sepsis. 
 
The authors concluded that literature at the time of publication did not support use of  
 
CRP in women with PPROM.(55) 
 
However, a study published in 2016 by Caloone et al (56) compared various markers  
 
in maternal serum that could possibly predict histological chorioamnionitis in  
 
PPROM. The markers studied were C-Reactive Protein (CRP), Interleukin-6 (IL-6),  
 
Interleukin-8 (IL-8), Triggering receptor on myeloid cells (TREM-1), InterCellular 
 
Adhesion Molecule-1 (ICAM-1), Human Neutrophile Peptides (HNP) and Matrix- 
 
Metalloproteinase 8 and 9 (MMP-8, MMP-9). They found that the concentrations of  
 
CRP, MMP-9, MMP-8 and HNP were higher in histological chorioamnionitis versus  
 
the non-Histological chorioamnionitis group (P<0.05). Among these, the ROC curve  
 
with the highest area under the curve, and significantly higher than other markers was  
 
C-RP. The authors concluded that C-RP was the best maternal marker to predict  
 
histological chorioamnionitis. 
 
3. Other Laboratory Tests 
 
Interleukin 6, Lipopolysacharide binding protein (LBP) and soluble intercellular  
 
adhesion molecule 1 (sICAM 1). Their clinical utility has not been established. 
 
 
4. Amniotic Fluid Testing 
 
Culture of amniotic fluid, usually obtained via amniocentesis has been used. However,  
 
results may not be available for upto 3 days, and given the invasive nature of the test,  
 
is hardly undertaken. 
40 
 
Placental and umbilical cord pathology 
 
Histological chorioamnionitis is diagnosed three times more frequently than clinical  
 
chorioamnionitis(57). This is in part because it encapsulates both clinical and sub- 
 
clinicalchorioamnionitis. Also, amniotic fluid cultures for genital mycoplasms, which  
 
are among the most common organisms causing chorioamnionitis, are not very 
 
sensitive. 
 
Histological chorioamnionitis has been defined as presence of acute histological  
 
changes on examination of the amniotic membrane and chorion of a placenta.  
 
Funisitis is the leucocytic infiltration of the wall of the umbilical vessel or Wharton‟s  
 
jelly (58). 
 
 
Differential Diagnosis of Chorioamnionitis 
 
Epidural- associated fever, Extra uterine infections: Pyelonephritis, appendicitis,  
 
pneumonia, influenza, etc. 
 
 
Effects on the fetus 
 
Goncalves et al (27) categorized intrauterine infection into 4 stages: 
 
 Stage 1 - Bacterial Vaginosis 
Stage 2 - Decidual Infection 
Stage 3 – Amnionic Infection 
Stage 4 – Fetal Systemic Infection 
 
Gomez et al (59) conducted a study to find out the frequency and significance of the  
 
fetal inflammatory response syndrome (FIRS) in women with PPROM/ Preterm  
 
Labour. They defined FIRS as elevated Interleukin-6 in fetal plasma. Amniocentesis  
 
andcordocentesis were performed in157 patients with preterm labour and PPROM.  
 
Investigators then cultured the amniotic fluid for aerobic/ anaerobic bacteria/  
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mycoplasms. Amniotic fluid and fetal plasma Interleukin-6 levels were measured. 
 
Results: 105 patients with preterm labour and 52 patients with PPROM were included.  
 
The prevalence of severe neonatal morbidity (defined as Respiratory Distress  
 
Syndrome, pneumonia, suspected/ proven neonatal sepsis, intraventricular 
 
haemorrhage, necrotizing enterocolitis or periventricular leucomalacia) was 34.8%  
 
(54/155). 
 
These neonates had higher levels of IL-6 compared to neonates who did not develop  
 
severe neonatal morbidity (median 14.0 pg/mL, range 0.5 to 900 vs median 5.2pg/mL,  
 
range 0.3 to 900, respectively; P < .005). 
 
In order to trace the relationship between the presence of FIRS and neonatal outcome,  
 
a multivariate analysis was performed. The analysis was restricted to those neonates  
 
who delivered within 7 days of cordocentesis, in order to maintain a meaningful  
 
temporal relationship. In this subset, 39/73 patients had severe neonatal morbidity  
 
(53.4%). 
 
A cut of of>11 pg/mL was used to define FIRS, and it was found that those neonates  
 
that met this criteriahad a higher rate of severe morbidity than those that did not  
 
(77.8% [28/36] vs 29.7% [11/37], respectively; P < .001).Stepwise logistic regression 
 
showed that fetal plasma IL-6 levels was an independent predictor of severe  
 
neonatal morbidity (odds ratio 4.3, 95% confidence interval 1 to 18.5), when adjusted  
 
for cause of preterm delivery, gestational age of delivery, presence of clinical  
 
chorioamnionitis, amniotic fluid IL-6 results and culture. 
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Complications of Chorioamnionitis 
 
 Fetal/ Neonatal 
o Asphyxia and Respiratory Distress 
o Sepsis 
o Neurological effects - Cerebral Palsy, Periventricular 
Leukomalacia 
o Pneumonia 
o Grade 3/4 Intraventricular Haemorrhage 
o Perinatal death 
 Maternal 
o Endometritis 
o Postpartum haemorrhage 
o Sepsis 
 
- Neonatal Asphyxia and Respiratory Distress 
 
Alexander et al (60) found that infants exposed to chorioamnionitishad increased risk  
 
of  low Apgar (3 or less at 5 minutes), umbilical artery cord pH of 7.0 or less and  
 
meconium aspiration syndrome. After adjusting for confounders, these babies were  
 
significantly more likely to require delivery room intubation. 
 
Yoder et al (61) found that respiratory distress occurred in 20% of term infants in the  
 
presence of chorioamnionitis and only 2% when chorioamnionitis was absent. 
 
- Sepsis 
 
Yoder et al (61) found a higher rate of neonatal sepsis in term infants whose mothers  
 
were diagnosed with chorioamnionitis.Chorioamnionitis has found to be associated  
 
with up to 40% cases of early in onset neonatal sepsis (54). 
 
- Cerebral Palsy and Periventricular Leucomalacia 
 
It has been suggested that Chorioamnionitis leading to FIRS can lead to fetal brain  
 
injury which can cause subsequent cerebral palsy (62). 
 
Studies have shown elevated fetal plasma cytokines and elevated amniotic fluid  
 
cytokines in children who subsequently developed cerebral palsy (58,63). 
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A metaanalysis by Wu et al (64) was conducted on studies that studied the association  
 
between clinical/ histological chorioamnionitis and the cystic periventricular  
 
leucomalacia (cPVL) and cerebral palsy in children.  
 
 
Findings: 
 
In preterm infants: Clinical chorioamnionitis was significantly associated with both  
 
cPVL(RR, 3.0; 95% CI, 2.2-4.0) and cerebral palsy (RR, 1.9; 95% CI, 1.4-2.5). The  
 
risk ratio of histologic chorioamnionitis with cerebral palsy was 1.6 (95% CI, 0.9-2.7).  
 
Histologic chorioamnionitis was associated significantly with cPVL 
 (RR, 2.1; 95% CI, 1.5-2.9). 
 
Full term infants: A positive association in full term infants between clinical  
 
chorioamnionitis and cerebral palsy was found (RR, 4.7; 95% CI, 1.3-16.2). 
 
Thus, investigators concluded that chorioamnionitis is a risk factor for both cPVL and  
 
cerebral palsy. 
 
- IntraventricularHemorrhage (IVH) 
 
Morales et al (65) found a statistically significant increase in rate of IVH in the setting  
 
ofchorioamnionitis. 
 
Complications of chorioamnionitis in Pretermversus Term 
 
Preterm infants are at even higher risk of all the complications of chorioamnionitis 
 
than term infants. 
 
- Perinatal death (25% vs 6%, preterm vs term) 
- Neonatal Sepsis (28% vs 6%) 
- Pneumonia (20% vs 3%) 
- Grades 3 /4 IVH (24 vs 8%) 
- Respiratory Distress (62 vs 35%)   (65) 
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Treatment of Chorioamnionitis 
 
This is done with broad spectrum antibiotics as soon as diagnosis is established to  
 
treat mother and baby. Treatment is not complete, however, without complete  
 
evacuation of the uterus of the products of conception. Hence, a plan for delivery  
 
should be made, either by induction/ augmentation of labour or if other indications, 
 
for example fetal distress coexist, caesarean section. The standard antibiotics used are  
 
Inj. Ampicillin 2 grams IV every 6 hours, and Inj. Gentamicin 1.5mg/kg every 8  
 
hours. 
 
In case of caesarean delivery, additional coverage with an antibiotic that covers  
 
anaerobes (eg. Metronidazole), is required as these patients are at greater risk for  
 
post partumendometritis. 
 
The baby also requires a blood culture postnatally and coverage with antibiotics. 
 
 
Prevention of chorioamnionitis 
 
Central to prevention of chorioamnionitis is the administration of antibiotics to  
 
women with PPROM. This strategy prolongs latency, decreases incidence of  
 
chorioamnionitis and improves neonatal outcomes.  
 
 
 
OTHER COMPLICATIONS OF PPROM 
 
 
A. Prematurity related morbidity has already been discussed at length. 
 
B. Cord Prolapse 
 
Malpresentations can lead to cord prolapse. Lewis et al (66)conducted a retrospective  
 
study of preterm pregnancies, 74 with vertex and 74 with non-vertex presentations.  
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They found a higher rate of cord prolapse in the non-vertex (n = 8; 10.8%) compared  
 
to the vertex group (n = 1; 1.4%). More infants in the non-vertex group  
 
had low Apgar scores and cord pH levels than in the vertex group. Five infants  
 
underwent a non plannedprecipitous vaginal breech delivery, but with no significant  
 
morbidity. 
 
They concluded that after transfer to the antenatal ward, patients with non-vertex  
 
pregnancies appeared to have a significantly higher risk of cord prolapse, low Apgars 
 
and low cord pH. 
 
 
 
C. Abruptio Placenta 
 
Abruption is found to occur in 2-5% of pregnancies with PPROM (67,68). This risk  
 
was found to be increased seven to nine fold where these pregnancies are complicated  
 
by chorioamnionitis or severe oligohydramnios(67,69). 
 
D. Fetalmalpresentations 
 
This can occur frequently, as it is well known that breech presentations are more  
 
frequent with decreasing gestational age. Another contributing factor is the decreased  
 
amniotic fluid that accompany these cases. 
 
 
 
E. Pulmonary hypoplasia, orthopaedic abnormalities and facial deformation 
 
These are rare, and occur with very early, severe, prolonged PPROM. 
 
F. Higher rates of Caesarean Section 
 
This can occur due to higher rate of malpresentations, fetal distress intrapartum due to  
 
decreased liquor; or failed induction of labour. 
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G. Infections 
 
Infections due to rupture of membranes are usuallypolymicrobial. The organisms  
 
isolated from amniotic fluid culture are usually enteric/ vaginal flora. 
 
Organisms isolated from amniotic fluid of 404 patients with chorioamnionitis 
 
Organism 
  
Percent 
 
Number 
Ureaplasmaurealyticum 
  
 
47.0 190 
Any gram-negative 
anaerobe 
 
38.4 155 
  
Mycoplasma hominis 
   
30.4 123 
Bacteroidsbivius 
   
29.5 119 
Gardnerellavaginalis 
  
24.5 
 
99 
Group B Streptococcus 
   
14.6 59 
Peptostreptococcusspp   
  
9.4 38 
Escherichia coli 
   
8.2 33 
Enterococci 
   
5.4 22 
Fusobacteriumspp 
  
Bacteroidesfragilis 
   
5.4 22 
 
(Source: Sperling et al Intraamniotic infection in low-birth-weight infants. J Infect Dis 
1988; 157:113.) (70) 
 
 
MANAGEMENT OF PPROM 
 
Diagnosis of PPROM  is first confirmed via history, speculum examination, fern test,  
 
Actim PROM as required.The approach to a patient, once the diagnosis of PPROM  
 
has been confirmed, is based on the following considerations: 
 
 Gestational age 
 Presence or absence of infection 
 Presence or absence of labour, Cervical status (by visual inspection)  
 Fetal well-being 
 Fetal presentation  
 Fetal lung maturity 
 Availability of neonatal intensive care 
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PPROM can be managed in two ways: either immediate delivery or expectant  
 
management.  
 
Before making this decision, one must rule out contraindications to expectant  
 
management. These are 
 
1. The presence of sepsis 
2. Cord prolapse/ risk of the same due to unstable lie 
3. Non reassuring fetal status 
4. Abruptio Placentae 
 
Abruptio Placentae and Cord Prolapse are ruled out via clinical examination.  
 
A thorough clinical examination is done to rule out sepsis, aided by laboratory tests –  
 
Total and Differential White Blood Cell Count, C-RP.  An ultrasound is performed to  
 
rule out growth restriction, confirm presentation, calculate amniotic fluid index and  
 
gain a rough estimate of baby weight. Non Stress Test is performed to confirm fetal 
 
well being. Neonatal consultation is sought, in the event of early delivery.  
 
If any complications are present, there is no role for expectant management,  
 
and one must immediately deliver the patient either vaginally, or if need be, by  
 
Caesarean section. 
 
 
Once complications are ruled out, the woman is administered a course of steroids for  
 
fetal lung maturity. She is also given a course of antibiotics, as this has been shown to  
 
improve outcomes and prolong latency.Once we have ensured fetal and maternal well  
 
being, the decision to deliver immediately or manage expectantly must be made. 
 
Before 34 weeks, most experts agree on management, and that is to prolong  
 
pregnancy with close monitoring. In the event of any complications, pregnancy is  
 
terminated by immediate delivery either via vaginal or caesarean delivery.  
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Expectant Management 
 
 Administration of Antenatal Corticosteroids:  
 
A landmark paper published in 1972 by Liggins et al demonstrated that administering  
 
steroids to women at risk of preterm delivery decreased the respiratory morbidity as  
 
well as mortality in offspring (71).  Antenatal steroid have been shown to accelerate  
 
development of certain key cells in the lungs – type 1 and type 2 pneumocytes –  
 
leading to biochemical and structural changes in the lungs. These changes improve  
 
lung mechanics (maximal lung volume and compliance) and improve gas exchange  
 
(66). 
 
The following adverse outcomes have been shown to decrease in preterm neonates    
 
when administered steroids antenatally 
 
- Respiratory Distress Syndrome 
- Intra Ventricular Haemorrhage 
- Necrotising Enterocolitis 
- Neonatal Mortality 
- Risk of infection in the first 48 hours (73). 
 
A 2006 Cochrane review by Roberts et al (73) showed significant benefit of Antenatal  
 
Corticosteroids when administered from 26 to 34 weeks of gestation. It is  
 
usually not administered after 34 weeks, provided one is sure of gestational age. 
 
 Antibiotics: 
 
As previously stated, infection may be the cause, or effect of PPROM. Antibiotics  
 
seem to prolong the latency, and treat/ prevent any such infection. 
 
A 2013 Cochrane review (74)of 22 randomised studies involving more than 6800  
 
women studied the use of antibiotics in women before 37 weeks of gestation. 
 
Compared to placebo, the use of antibiotics was found to have the following benefits  
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with significant reductions in  
 Babies born within 48 hours (RR 0.71, 95% CI 0.58-0.87) and 7 days (RR 
0.79, 95% CI 0.71-0.89) of randomization  
 Chorioamnionitis (RR 0.66, 95% CI 0.46-0.96)  
 Use of surfactant (RR 0.83, 95% CI 0.72-0.96) 
 Neonatal oxygen therapy (RR 0.88, 95% CI 0.81-0.96) 
 Neonatal infection (RR 0.67, 95% CI 0.52-0.85) and 
 Abnormal cerebral ultrasound scan prior to hospital discharge (RR 0.81, 95% 
CI 0.68-0.98) 
 
No definite regimen was found to show more benefit than the others, however use of  
 
Amoxicillin – Clavulunate was found to be associated with the incidence of  
 
necrotisingenterocolitis in the offspring. In CMC, a 5 day course of  
 
Tab. Azithromycin 250mg twice a day with Tab. Metronidazole 400 mg thrice a day  
 
for a duration of 5 days is used. 
 
 Use of Tocolysis/ Progesterone 
 
Neither of these therapies has been found to be of use in these patients. 
 
 Home care versus Hospitalisation 
 
A Cochrane review was published in 2014 assessing safety and cost for home versus  
 
hospital care for women with PPROM (75) . They were able to include only two trials  
 
comprising a total of 116 women. These studies did not show a significant difference  
 
in neonatal morbidity/ mortality. They found that women who stayed at home were  
 
more satisfied with their care, had a shorter duration of hospital stay by approximately  
 
10 days and had fewer costs. However, women who were hospitalised seemed more  
 
likely to have caesarean delivery.  
 
The authors concluded that these studies were inadequately powered, and further,  
 
larger randomised trials were required before a recommendation could be made. 
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 Maternal monitoring 
 
This should be done vigilantly for signs of infection. In CMC, a twice weekly blood  
 
counts, with CRP is done to monitor for infection, however studies have not found  
 
this to be of much use (54). 
 
They should also be warned of  complications that may arise, and report any fever,  
 
foul smelling lochia, decreased fetal movements, abdominal pain or bleeding per  
 
vaginum. 
 
 Fetal Monitoring 
 
Some form of fetal surveillance has to be undertaken to assure fetalwell being(76).  
 
No definite method is agreed upon. Some of the methods used are – daily fetal kick  
 
count, daily Non Stress Test/ Bio Physical Profile. 
 
 
 Delivery 
 
Timing of delivery should be decided after discussing the pros and cons of expectant  
 
management versus immediate delivery with the patient. Once delivery has been  
 
decided upon, if no contraindication to vaginal delivery exists, one can induce labour  
 
using Prostaglandin E2, or oxytocin directly as per the Bishops Score. 
 
 
 Future Pregnancies 
 
The risk of recurrence must be explained, as well as the association with preterm birth.  
 
Supplemental progesterone or cervical length monitoring with cerclage placement can  
 
be considered in these cases. 
 
Beyond 34 weeks, there is no consensus on key management issues. 
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ACOG Guidelines 2013 
 
- Patients with PPROM <34 weeks should be managed expectantly if no  
other contraindications to the same exist (Level A). 
 
- A 7 day course of antibiotics with a combination of Erythromycin or 
Ampicillin/ Amoxicillin is recommended in women on expectant 
management <34 weeks, this reduces maternal/ neonatal infections and 
gestational age dependent morbidity (Level A) 
 
- A single course of antenatal corticosteroids are recommended for these 
women who are 24 +0/7 to 34 +0/7 weeks and at are risk of delivery. 
 
 
Greentop Guideline Number 44(6) published in 2006 recognises that the decision to 
 
deliver beyond 34 weeks is one that should not be taken lightly. The increased risks  
 
associated with perinatal morbidity when a late preterm delivers should be weighed  
 
againsttherisks of chorioamnionitis and its effects on baby and mother when one tries  
 
to prolong pregnancy.  Most studies did not find a difference in major 
 
neonatal composite morbidity if delivery occurred at 34 weeks. There was also not  
 
enough research done in the subgroup of 34 to 37 weeks.  
 
Hence, it was concluded that delivery be considered at 34 weeks of gestation.  
 
Expectant management could also be considered with the caveat of adequate  
 
counselling to the mother – the risks of chorioamnionitis versus the benefits of  
 
decreased respiratory morbidity. 
 
The following are a list of consequences that must be considered with either line of  
 
management. 
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Pregnancy complications with PPROM 
 
Pregnancy complication 
   
Potential consequences for 
offspring 
Potential maternal 
consequences 
Intrauterine infection Neonatal sepsis 
Cerebral palsy, other 
neurodevelopmental 
abnormalities 
 
Postpartum endometritis 
 
Oligohydramnios Umbilical cord compression, 
Fetal Asphyxia 
 
Cesarean delivery 
Fetalmalpresentation Cord Prolapse - asphyxia Cesarean delivery 
 
Abruptio placentae Asphyxia Cesarean delivery, 
Coagulopathy 
 
Preterm birth Morbidity of prematurity, 
including patent 
ductusarteriosus , 
intraventricularhemorrhage, 
respiratory abnormalities, 
necrotizing enterocolitis, 
retinopathy of prematurity,  
Failed induction - Cesarean 
delivery 
 
 
(Reproduced from UptoDate.com) 
 
The need for more research on this subject has been noted, and there have been  
 
randomised control trials on this subject to address these clinical questions. 
 
Two notable studies are - PPROM Expectant Management versus Induction of Labor 
 
(PPROMEXIL)(77) and PPROMT trial (Immediate delivery compared with 
 
expectant management after preterm pre-labour rupture of the membranes close to  
 
term(78). 
 
These trials brought to light the advantages and disadvantages of prolonging  
pregnancy in late preterms with PPROM. 
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Advantages of Expectant Management (from 34+0/7 to 37+0/7 weeks) 
 
There does not seem to be an increased risk of neonatal sepsis as previously thought  
(77,78).  
There is a higher probability of vaginal delivery when these patients are carried closer  
to term (77,78).  
There is also less neonatal morbidity when these patients are carried to term. Morris et 
al demonstrated that those delivering immediately had higher rates of respiratory  
distress (76 [8%] of 919 vs 47 [5%] of 910, RR 1·6, 95% CI 1·1-2·30; p=0·008) and  
any mechanical ventilation (114 [12%] of 923 vs 83 [9%] of 912, RR 1·4, 95% CI  
1·0-1·8; p=0·02) (78).  
In those undergoing immediate delivery, babies spent more time in neonatal intensive  
care (median 4·0 days [IQR 0·0-10·0] vs 2·0 days [0·0-7·0]; p<0·0001) (78). 
 
Disadvantages of Expectant Management (from 34+0/7 to 37+0/7 weeks) 
 
These women had higher rates of chorioamnionitis and need for intrapartum 
 
antibiotics than those undergoing immediate delivery. 
 
Morris et al found that women who undergo expectant management have higher risks  
of intrapartum/antepartumhemorrhage (RR 0·6, 95% CI 0·4-0·9), occurrence of  
intrapartum fever (0·4, 0·2-0·9), and the use of postpartum antibiotics (0·8, 0·7-1·0)  
with a longer hospital stay (p<0·0001) (78). 
 
 
In the absence of obvious infection, when fetal well being is assured, a 
policy of expectant management with prudent surveillance of maternal as well as fetal 
wellbeing should be followed in women with PPROM close to term. 
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METHODOLOGY 
 
This was a prospective, non inferiority randomised control trial to ascertain whether 
conservative management   of preterm prelabour rupture of membranes   had similar neonatal  
and maternal outcomes in comparison to immediate delivery, in pregnant women after 34  
weeks of gestation till 37 completed weeks.  
The trial was presented before the Institutional Review Board in Christian Medical College 
and Hospital (CMCH), and protocol was approved prior to start of recruitment. 
All pregnant women admitted to the Christian Medical College Labour ward between 34 +0/7  
and 36 +6/7 weeks of gestational age with complaints of leaking per vaginum were screened  
for eligibility to this trial. 
 
Pregnant womenbooked in CMCH were informed of this study at first antenatal visit,  
through information sheets given in OPD. If they were willing to be part of this study,  
informed consent was taken at the next antenatal visit. 
 
Those who subsequently presented with rupture of membranes between 34+0 to 36weeks and  
6 days of gestational age were included in this study. All pregnant women reporting to labour  
room with preterm prelabour rupture of membranes (leaking per vaginum from 34 to 36+6  
weeks of gestation) were eligible. Pregnant women who were booked elsewhere , but referred 
to CMC labour ward and meeting inclusion criteria, were also included in the study after 
taking informed consent. 
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After confirmation ofPPROM, by means of definite history of leaking, direct visualization of 
amniotic fluid in the posterior fornix with speculum examination or using an enzyme-linked  
immunosorbent assay (ELISA) test to confirm leaking, patients were enrolled into the study. 
Exclusion criteria were suspected chorioamnionitis (determined by clinical examination ,  
Total WBC count >15,000, C-RP >5, Differential WBC Count with band forms), the  
presence of labour (presence of uterine contractions and cervical dilatation >=2cms) , severe  
oligohydramnios ( AFI <= 5 cms), malpresentations (transverse lie and footling breech),  
suspected abruption and fetal compromise.  Pregnancies with flexed/ extended breech  
presentations were included in the trial. 
All consenting and eligible women were randomized to either the immediate delivery  
or conservative management group.  In the immediate delivery group, induction of  
labour/ caesarean section was carried out as per protocol. If randomized to expectant  
managementgroup, pregnancy was allowed to continue till 36 completed weeks, in the  
absence of any maternal/ fetal complications, and induction of labour /LSCS was  
carried out as per protocol at 37 weeks. 
 
In the Expectant Management group, women received a course of oral antibiotics  
(Tab. Azithromycin/ Tab. Metronidazole) and antepartum surveillance was carried out  
for fetal and maternal well being.  The components of antepartum surveillance are  
described below: 
 Admission of pregnant women to antenatal ward with biweekly ultrasounds for 
modified biophysical profile. 
 Biweekly maternal blood test (CRP) to detect subclinical chorioamnionitis.  
 Strict daily clinical monitoring for signs of chorioamnionitis – Maternal  
fever/ tachycardia, uterine tenderness, foul smelling discharge per vaginum. 
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Women were discharged after one week if there were no maternal and fetal complications, at 
the discretion of senior consultant fromthe respective Unit and advised to return to the  
antenatal clinic for biweekly visits.  At discharge, womenwere given instructions to return  
immediately to labour ward in the event of fever, foul smelling discharge per vaginum,  
abdominal pain, vaginal bleeding, decreased or absent fetal movements. Antenatal per vaginal  
examinations in the absence of labour were not carried out. Conservative management was 
terminated in the presence of chorioamnionitis, fetal compromise,onset of spontaneous  
labour, suspected abruption or any condition necessitating early delivery. 
 
Blinding was not possible after randomisation due to the inherent nature of the study  
design. 
Baseline data was collected for all patients, which included body mass index, age,  
socioeconomic status, time and date of rupture of membranes. Additional information  
was collected after delivery, such as randomisation to delivery interval, data  
pertaining to the neonate, mode of delivery, post natal course of the mother. 
 
Primary outcome was the occurrence of neonatal sepsis, which was defined as proven  
neonatal infection  with positive blood culture within 48 hours of birth. 
Secondary outcomes includedthe  
occurrence of neonatal and maternal adverse outcomes. All babies were assessed by a  
Neonatologist at birth, and need for ICU care/ antibiotics decided by the treating  
Neonatologist. Neonatal morbidity was also be recorded by the treating neonatologist. 
Secondary Neonatal Outcomes  
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- Mode of delivery 
- Apgar score at 0 and 5 minutes 
- Need for resuscitation at birth 
- Cord pH at the time of delivery (In case of low Apgar) 
- Respiratory distress syndrome (RDS) 
- Pneumonia 
- Meconium aspiration syndrome 
- Late onset neonatal sepsis 
- Hypoglycaemia 
-  Necrotizing enterocolitis 
- Convulsions 
- Intrauterine death/ Neonatal death 
- Total length of hospital stay and admission 
- Need for admission to neonatal intensive care unit (NICU), and if required, 
length of stay in NICU 
- Need for Readmission 
 
Secondary Maternal Outcomes-   
- Clinical chorioamnionitis (defined as fever before or during labor with a 
temperature greater than 100.4degreesF, requiring antibiotics)  
- Maternal sepsis (defined as a temperature greater than 100.4degreesF and a 
positive blood Culture or circulatory instability requiring intensive care 
monitoring) 
- Antepartum hemorrhage (Bleeding per vaginum after 28 weeks gestation 
and before the onset of labour) 
- Umbilical cord prolapse 
- Urinary tract infection treated with antibiotics 
- Endometritis (defined as a temperature greater than 100.4 degrees F on two  
occasions at least 1 h apart after the first 24 h postpartum with associated 
uterine tenderness),  
- Post partum Haemorrhage (Blood loss after delivery >500ml after a vaginal 
delivery, >1000 ml after a caesarean section) 
- Total length of hospital stay 
-  Admission to the intensive care unit 
- Maternal death 
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SAMPLE SIZE CALCULATION 
 
 
 
 
 
Non-inferiority - Two Groups - Parallel - Two proportions - Equal Allocation 
Proportion in the standard treatment 0.02 
Proportion in the new treatment   0.02 
Observed/Expected difference in proportions 0 
Non-inferiority margin -0.02 
Power (1- beta) % 80 
Alpha Error % 5 
Required sample size in each group  606 
 
Assuming an equal incidence of neonatal sepsis in both arms (that is immediate delivery or prolonging  
 
pregnancy to 37 weeks), with a non inferiority margin of 20%, the calculated sample size is 606 in each  
 
arm. 
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Table 1 – Inclusion Criteria 
                    Inclusion Criteria 
1. PPROM at 34 weeks upto 36 weeks and 6 days of gestation  
confirmed by definite history/ positive ELISA test for PPROM / Direct  
visualization of amniotic fluid in the posterior fornix on speculum  
examination 
 
 
Table 2 – Exclusion Criteria 
 Exclusion Criteria 
1. Preterm labour 
2. Evidence of clinical or subclinical chorioamnionitis 
3. Fetal distress 
4. High risk pregnancy necessitating immediate delivery 
5. Major congenital anomalies of fetus 
6. Oligohydramnios 
7. Malpresentation (transverse lie and footling breech) 
8. Suspected abruption 
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RESULTS 
A total of 10,692 patients were admitted to the Christian Medical College Labour  
ward between December 2015 and August 2016, out of which 1003 were 34 to 36 +6  
weeks of gestational age. One hundred and fifty seven (157) of these patients were  
admitted with complaints of leaking per vaginum and were screened for inclusion in  
this study. One hundred and eighteen (118) were excluded due to the following  
reasons. Thirteen patients were unwilling to participate, thirty two had regular  
contractions with cervical dilatation >= 2 cms, twenty nine could not be recruited due  
to associated risk factors such as severe preeclampsia. Five patients were induced for  
clinical chorioamnionitis. Thirty nine patients had elevated CRP/ white blood cell  
counts that precluded them from the trial.  
 
Table 3 – Patients with PPROM from December 2015 to August 2016 
Total Elevated 
CRP/ 
Counts  
Clinical 
Chorioamnionitis 
Spontaneous 
Labour 
Associated 
Risk 
Factors 
Not 
willing 
Recruited 
157 39 5 32 29 13 39 
 
Finally, we were able to recruit 39 patients, of which 20 were randomised to  
immediate delivery and 19 to expectant management. 
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10,692 Patients admitted to CMCH Labour Ward 
 
 
1003 Patients were 34 to36+6 weeks of gestation 
 
 
157 Patients had PPROM 
 
118 Excluded 
- 13 did not wish to participate 
- 32 were in labour 
- 5 clinical chorioamnionitis 
- 39 with elevated CRP/ counts 
- 29 had associated morbidity 
 
39 Recruited and Analysed 
 
 
20 randomised to Immediate Delivery           19 randomised to Expectant Management 
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When we followed up those that were excluded due to increased CRP/ counts, we  
found that 37 patients had been delivered immediately.  
Table 4– Follow up of Patients with elevated CRP/ Counts 
 Yes No 
Delivered 
Immediately  
37 
 
1 (9 days gained, had 
NICUadmission) 
+1 (3 days gained) 
Neonatal 
Sepsis 
 
2 (suspected) 38 
(1 set of twins) 
Maternal 
complications 
1 – post partum Fever – UTI 38 
NICU 
Admission 
20 
+2 – VSD 
+1 – Anomalous, END 
17 
NICU – Neonatal Intensive Care Unit, UTI – Urinary Tract Infection, VSD – Ventricular septal 
defect, END – Early Neonatal Death 
Two patients underwent conservative management as decided by the treating  
consultant. These patients gained a total of 9 days and 3 days respectively, neither  
patients developed chorioamnionitis/ neonatal sepsis, but one baby needed NICU care  
for preterm morbidity. 
 
Of all the 40 babies born to these 39 mothers (one was a twin pregnancy), two babies  
developed suspected sepsis,  both needing second line antibiotics. The blood cultures  
for these babies were sterile. Twenty three babies needed ICU care, of which two had  
a VSD and one was an anomalous baby that died in the first week of life.  
One mother developed fever and was diagnosed with ESBL(Extended Spectrum Beta  
Lactamase producing) E. Coli positive UTI. There were no other maternal  
complications. 
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Baseline Characteristics 
The baseline characteristics are listed in tables 5 and 6. 
 
Table Number 5 – Baseline Characteristics. 
Baseline Characteristics Immediate Delivery Group 
N = 20 
Expectant Management 
Group 
N = 19 
DEMOGRAPHIC DATA   
1. Age 
              18-29 
>30 
 
18 (90%) 
2 (10%) 
 
14 (73.7%) 
5 (26.3%) 
2. Socioeconomic status 
Wood 
Kerosene 
LPG 
 
 
0 
3 (15%) 
17 (85%) 
 
0 
1 (5.3%) 
18 (94.7%) 
3. Occupation 
Unskilled labour 
Skilled worker 
Professional 
 
2 (10%) 
6 (30%) 
12 (60%) 
 
1 (5.3%) 
6 (31.6%) 
12 (63.2%) 
4. BMI 
17-22.9 
23-27.9 
>28 
 
 
7 (35%) 
6 (30%) 
7 (35%) 
 
3    (15.8%) 
10   (52.6%) 
6   (46.2%) 
PARITY 
1. Primipara 
2. Multipara 
 
 
15 (75%) 
5 (25%) 
 
11 (57.9%) 
8 (42.1%) 
ANTENATAL RISK 
FACTORS 
  
1. Previous LSCS 0 1 (5.3%) 
2. Anemia 1 (5%) 0 
3. Gestational Diabetes 3 (15%) 3 (15.8%) 
4. Twin Gestation 0 1 (5.3%) 
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Age:Majority of the patients recruited were in the age group of 18 – 30 years. Two  
patients in the Immediate Delivery arm and 5 patients from the Expectant  
Management arm were above 30 years of age. There were no patients at or above the  
age of 35. 
Graph 1 – Age wise Distribution in each arm 
 
 
Socioeconomic Status: We asked the patients what fuel they used in the home for  
cooking as a measure of their socioeconomic status. Majority of our patients used  
LPG (85% in the Immediate Delivery arm and 94.7% in the Expectant Management  
arm). The rest of our patients used Kerosene. None of our patients used firewood. 
Graph 2 –Socioeconomic Status in each arm 
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BMI-In the range of 17 to 22.9 kg/m2, there were 7 (35%)patients in the Immediate  
Delivery Arm and 3 (15.8%) patients in the Expectant Management Arm. In the BMI  
range of 23 to 27.9 kg/m2 there were patients in the 6(30%) Immediate Delivery Arm  
and10 (52.6%)patients in the Expectant Management Arm. Above the BMI of 28,  
there were 7 (30%) patients in the Immediate Delivery Arm and 6 (46.2%) patients in  
the Expectant Management Arm. There were no morbidly obese patients. 
Graph 2 –Patients grouped according to BMI in each arm 
 
 
Parity- Majority of the patients in the Immediate delivery arm were primigravidas 
(75%), compared to 57.9% of those in the Expectant Management arm.  Twenty five  
percent in the immediate delivery arm and forty two percent in the expectant  
management arm were multiparous. 
Graph 3 –Patients grouped according to parity in each arm 
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Antenatal Risk Factors: One patient in the Expectant Management group had a  
previous LSCS, three in each group were diabetic, while one patient in the Immediate  
Delivery arm had anemia requiring blood transfusion antenatally.  
There was one Diamniotic Dichorionic twin gestation in the Expectant Management  
arm. Twins with PPROM have not thus far been studied, and this case will be  
discussed in detail at a later stage. 
Graph 4 –Antenatal Risk Factors in each arm 
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Table 6 - Baseline Characteristics 
Baseline Characteristics Immediate Delivery Group 
N = 19 
Expectant Management 
Group 
n = 20 
FETAL PRESENTATION 
1. Cephalic 
2. Breech 
 
19 (95%) 
1 (5%) 
 
19 (100%) 
0 
STEROIDS RECEIVED 1 (5%) 0  
MODE OF DIAGNOSIS 
1. Speculum examination 
2. Positive Ferning 
3. Definite History 
4. ELISA test (Actim 
PROM) 
 
 
18 (90%) 
0 
0 
2 (10%) 
 
16 (84.2%) 
0 
3 (15.7%) 
0  
GESTATIONAL AGE AT 
PPROM 
1. <34 weeks 
2. 34+0 to 34 +6 
weeks 
3. 35 +0 to 35+6 
weeks 
4. 36+0 to 36+6 
weeks 
 
 
 
1 (5%) 
3 (15%) 
 
10 (50%) 
 
6 (30%) 
 
 
0 
7 (36.8%) 
 
6 (31.6%) 
 
6(31.6%) 
MEAN GESTATIONAL AGE 
AT PPROM 
35+4 weeks 35+2 weeks 
GESTATIONAL AGE AT 
RECRUITMENT 
1. 34+0 to 34 +6 
weeks 
2. 35 +0 to 35+6 
weeks 
3. 36+0 to 36+6 
weeks 
 
 
 
4 (20%) 
 
10 (50%) 
 
6 (30) 
 
 
7 (36.8%) 
 
6 (31.5%) 
 
6 (31.5%) 
MEAN GESTATIONAL AGE 
AT RECRUITMENT 
35+4 Weeks 35+1 Weeks 
ANTIBIOTICS RECEIVED 
1. During Admission 
(A/F) 
2. During Labour 
(ampicillin) 
 
 
14 (70%) 
 
20(100%) 
 
19 (100%) 
 
19(100%) 
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Other Baseline Characteristics: 
Fetal Presentation: Majority of the babies were cephalic in presentation. One baby in  
the immediate delivery arm was flexed breech. 
Graph 5 - Fetal Presentation in each arm 
 
 
Steroid Course: As per hospital policy, only women with <34 weeks of pregnancy   
receive steroids for lung maturity. There was only one such patient that presented  
before 34 weeks, and was subsequently recruited into the immediate delivery arm. 
D osing PPROMf diagn 
Metho:Ninety percent of patients in the immediate delivery arm were  
diagnosed by direct visualisation of liqour in the posterior vaginal fornix on speculum  
examination, as compared to 84.2 % of the Expectant Management arm. On the other  
hand, 15.7% of those in the Expectant Management arm were diagnosed by a definite  
history of leaking per vaginum, corroborated by a senior obstetrician, as compared to  
none in the Immediate Delivery arm. Ten percent of those in the Immediate Delivery  
arm were diagnosed by the ELSIA test, Actim PROM. 
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Graph 6 – Mode of Diagnosis 
 
 
 
Gestational Age at PPROM 
Most of the patients in the Immediate Delivery arm had rupture of membranes at  
35+0/7 to 35+6/7 weeks (50% of patients). Thirty percent and fifteen percent ruptured  
membranes in their 36
th
 and 34
th
 week respectively. One patient had of membranes at  
< 34 weeks (33 weeks and 2 days of gestation).The mean gestational age at rupture of  
membranes for this group was 35+4 weeks. 
In the Expectant management arm, patients had a more or less uniform distribution of  
rupture of membranes from 34 to 36+6/7 weeks. There were no patients that had  
rupture of membranes before 34 weeks. The mean gestational age at rupture of  
membranes for this group was 35+2 weeks. 
Graph 7 – Gestation at Rupture of Membranes 
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Gestational Age at Recruitment 
In the Immediate Delivery arm, 50% of patients were recruited between 35+0 to 35+6 
weeks, 20% from 34 to 34+6 weeks and 30% from 36 to 36+6 weeks. The mean  
gestational age at recruitment in this group was 35+4 weeks. 
In the Expectant Management, 36.8% were recruited at 34 to 34+6 weeks, and 31.5%  
each were recruited in their 34
th
 and 36
th
 week of gestation. The mean gestational age  
at recruitment in this group was 35+1 weeks. 
Graph 8 – Gestational age at Recruitment 
 
 
Antibiotics received by mother: All patients in the Immediate Delivery group received  
IV antibiotics in labour (Inj. Ampicillin) for prophylaxis against Neonatal Group B  
Streptococcal infection. All patients in the Expectant Management received a full 5  
day course of oral antibiotics (Tab. Azithromycin and Tab. Metronidazole) and  
received IV antibiotics if they delivered before 37 weeks gestation. 
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PRIMARY OUTCOME 
Table 7 – Incidence of Neonatal Sepsis 
Outcome Measure Immediate 
Delivery 
Group 
Expectant 
Management 
Group 
„p‟value Total 
1. Neonatal Sepsis 
- Culture Proven 
- Probable sepsis 
(late onset) 
 
1 (5%) 
1 (5%) 
 
0 
0 
 
0.25 
 
2 (10%) 
 
 
There were two patients in the Immediate Delivery arm that were diagnosed with  
sepsis.  One baby‟s blood culture at birth was positive, with significant growth of  
ESBL E.Coli. This baby was born at 35+6 weeks, with a birth weight of 2080 grams.  
There was no evidence of chorioamnionitis in the mother, either antenatally or during  
labour. This baby also had a low Apgar score at birth (5, 8). Cord pH, however, was  
normal. The baby spent 9 days in the Neonatal ICU on IV Antibiotics, but did not  
need ventilatory support. The baby was well at discharge. 
 
The second baby was born at 35+6 weeks, with a birth weight of 2220grams. This  
baby was diagnosed with imperforate anus, cleft palate and patent foramen ovale post  
natally. The baby underwent sigmoid loop colostomy. Initial blood cultures were  
negative, however baby was diagnosed with probable sepsis on Day 17. In  
consultation with senior Neonatologist, the authors agree that this diagnosis is  
unrelated to the preterm rupture of membranes. 
 
None of the babies in the Expectant management arm developed sepsis. 
The p value for neonatal sepsis was 0.2, therefore not significant. However, due to the  
small numbers obtained, this should be interpreted with caution.   
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SECONDARY OUTCOMES 
Table 8 - Details of Labour 
Outcome Measure Immediate 
Delivery 
Group 
N= 20 
Expectant 
Management 
Group 
N = 19 
„p‟value Total 
 
 
1. Onset of labour 
 
-Spontaneous labour 
-Induction of labour 
-Caesarean Section 
 
 
 
 
2. Chorioamnionitis 
 
 
3. Mode of delivery 
- Vaginal, spontaneous 
- Vaginal, instrumental 
- LSCS 
 
Indication of LSCS 
- Fetal Distress 
- Failed Induction 
 
4. Antepartum hemorrhage 
 
5. Umbilical cord prolapse 
 
6. Post partum Haemorrhage 
 
 
 
 
 
 
 
- 
19 (95%) 
1 (5%) 
 
 
 
 
0 
 
 
 
15 (75%) 
3 (15%) 
2 (10%) 
 
 
1 (5%) 
1 (5%) 
 
 
0 
 
0 
 
1 (5%) 
 
 
 
 
 
      9(47.3%) 
10 (52.6%) 
- 
 
 
 
 
1 (5.2%) 
 
 
 
13 (68.4%) 
2 (10.5%) 
4 (21.1%) 
 
 
2 (10.5%) 
2 (10.5%) 
 
 
0 
 
0 
 
0 
 
 
 
 
 
 
 
 
 
 
 
 
0.2 
 
 
 
 
0.6 
 
 
 
 
 
 
 
- 
 
- 
 
0.2 
 
 
 
 
 
 
39 
 
 
 
 
 
1 (2.5%) 
 
 
 
39 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Onset of Labour:Nineteen of the twenty patients in the immediate delivery arm  
underwent induction of labour.One patient had a breech presentation, and underwent  
LSCS for fetal distress. 
Ten patients in the Expectant Management group underwent induction of labour for  
various reasons. Nine patients went into spontaneous labour.  
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Chorioamnionitis: One patient in the Expectant Management arm developed  
chorioamnionitis 24 hours after recruitment and needed induction of labour. Post natal  
period for both mother and baby were uneventful. There were no patients in the  
Immediate Management group that developed chorioamnionitis. The p value was 0.2,  
insignificant, but must be interpreted with caution due to the low numbers obtained  
thus far in this study. 
 
Mode of Delivery: Almost equal numbers of patients in both arms underwent  
spontaneous vaginal/ instrumental deliveries. Four patients in the Expectant  
management underwent LSCS as compared to two patients in the Immediate Delivery  
arm. The p value was 0.6, there was no statistical significant difference found between  
the groups. 
Graph 9 – Mode of delivery in both groups 
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Table 9 - Outcomes withExpectant Management 
 Expectant 
Management 
Total 
1. Reason for termination of 
Expectant Management 
 
- Completed 37 weeks 
- Spontaneous Labour 
- Chorioamnionitis 
- Decreased fetal 
movements 
- Continued leaking and 
low Amniotic Fluid 
Index 
 
 
 
 
5 (26.3%) 
9 (47.3%) 
1 (5.2%) 
3 (15.7%) 
 
1 (5.3%) 
 
 
 
 
19 
2. Time gained 
 
- <1 day 
- 2 – 6 days 
- 1 – 2 weeks 
- 2 – 3 weeks 
- >3 weeks 
 
 
2 (10.5%) 
10 (52.6%) 
4 (21.05%) 
1 (5.2%) 
2 (10.5%) 
 
 
 
19 
 
 
Reasons for Termination of Expectant Management: Nine (47.3%) of these patients  
went into spontaneous labour after recruitment. Five patients (26.3%) completed 37  
weeks and were subsequently induced. One patient developed chorioamnionitis, three  
complained of decreased fetal movements and one patient had continued leaking with  
severe oligohydramnios necessitating termination of expectant management. 
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Graph 10– Reasons for Termination of Expectant Management
 
 
Time gained by expectant management:  Two patients went into spontaneous labour  
within twenty four hours of recruitment. Ten (52.6%) patients gained between 2 – 6  
days after recruitment. Four (21%) patients gained between 1 and 2 weeks. One  
patient crossed 2 weeks after recruitment, and two patients gained over 3 weeks. We  
were able to continue five pregnancies till term. 
 
The minimum randomisation to delivery interval was 3 hours and 32 minutes. The  
maximum time gained was 33 days and 50 minutes, after which the patient was  
induced. 
Graph 11 – Time gained with Expectant Management 
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Table 10 – Randomisation to delivery interval in both arms 
 
 Immediate 
Delivery Arm 
Expectant 
Management Arm 
P value 
Randomisation to 
delivery interval  
(hours) 
Mean and SD 
 
12 hours 20 mins 
+/- 
7 hours 30 mins 
18 hours 29 mins +/-  
29 hours 51 minutes 
0.04 
 
The mean randomisation to delivery interval in the Immediate Delivery arm was 12  
 
hours and 20 minutes, with a standard deviation of 7 hours and 30 minutes as  
 
compared to 18 hours and 29 minutes , with a standard deviation of 29 hours and 51  
 
minutes in the expectant management arm. This difference was statistically significant  
 
(p value 0.04). 
  
 
Table 11 - Patients managed as Inpatient vs Outpatient 
 
 Managed as 
Inpatient 
Managed as 
outpatient 
Total 
Number of 
patients 
(expectant 
management 
arm) 
11 (57.8%) 8 (42.09%) 19 
Mean days of 
antenatal 
hospitalisation 
2.1 days 3.1 days -- 
 
In the Expectant Management arm, there were a total of 11 patients managed on an  
inpatient basis. The mean number of days of hospitalisation with these patients was  
2.1 days. Eight patients (42%) were managed on an outpatient basis at time of  
delivery. The mean duration of antenatal hospitalisation was 3.1 days.  
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Table 12 - Neonatal Complications 
Outcome Measure Immediate 
Delivery 
Group 
N= 20 
Expectant 
Management 
Group 
N = 20 
„p‟value Total 
 
1. Gestation at delivery 
34 +0 to 34+6 weeks 
35+0 to 35 +6 weeks 
36+0 to 36+6 weeks 
>37 weeks 
 
2. Apgar  
<= 5,8 
 
 
3. Need for resuscitation 
 
4. Asphyxia (cord pH<7.2) 
 
 
5. Necrotizing enterocolitis 
(+Patent 
DuctusArteriosus) 
 
6. Hyperbilirubinemia 
 
7. Hypoglycaemia 
 
8. Polycythemia requiring 
exchange transfusion 
 
9. Convulsions not 
attributable to asphyxia 
(Probable viral 
encephalitis) 
 
10. Neonatal Death/ 
Intrauterine death 
 
11. Meconium aspiration 
syndrome, Respiratory 
distress syndrome (RDS), 
Pneumonia, Late onset 
sepsis 
 
12. Infant death (2 months and 
11 days) 
 
3 (15%) 
10 (50%) 
7 (35%) 
0 
 
 
1 
 
 
2 
 
0 
 
 
1 
 
 
 
2 
 
5 
 
1 
 
 
1 
 
 
 
 
0 
 
 
 
 
 
0 
 
 
1 
 
 
2 (10%) 
4 (20%) 
9 (45%) 
5 (25%) 
 
 
0 
 
 
1 
 
0 
 
 
0 
 
 
 
0 
 
5 
 
0 
 
 
0 
 
 
 
 
0 
 
 
 
 
 
0 
 
 
0 
 
 
 
0.2 
 
5 (12.5%) 
14 (35%) 
16 (40%) 
5 (12.5%) 
 
 
1 (2.5%) 
 
 
3 (7.6%) 
 
- 
 
 
1 (2.5%) 
 
 
 
2 (5%) 
 
10 (25.6%) 
 
1 (2.5%) 
 
 
1 (2.5%) 
 
 
 
 
- 
 
 
 
 
 
- 
 
 
1 (2.5%) 
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13. Discharged against 
Medical Advice 
 
- Baby with anomalies, post 
surgery in critical 
condition 
- >10% Weight loss  
 
 
 
 
 
 
 
1 
 
0 
 
 
 
 
 
 
 
 
0 
 
1 
 
 
 
 
 
 
 
 
1 (2.5%) 
 
1 (2.5%) 
 
Neonatal Outcomes:  
The most common complication was hypoglycaemia, affecting 5 babies in each group. 
 
Expectant management Group 
Five babies (25% of patients) were delivered at term in the Expectant Management  
group. Another nine babies (45%) were delivered between 36 to 36+6/7 weeks. Four  
babies  (20%) were delivered between 35 to 35+6/7 weeks. Two babies (10%)  
weredelivered between 34 + 34+6/7 weeks. 
One baby required resuscitation at birth since Apgar was low. Cord pH, however,  
was normal.  Five babies had hypoglycaemia, none of the babies had  
hyperbilirubinemia. One patient who was advised continued admission due to >10%  
weight loss was discharged against medical advice. 
 
Immediate Delivery Group 
In the Immediate Delivery group, 50% of the babies (10 babies) delivered between 35  
and 35+6/7 weeks, 35% (7 babies) were above 36 weeks and 15% (3 babies) delivered  
at<34 weeks. 
Two babies in the Immediate delivery group needed resuscitation, one of which had a  
low Apgar (score of 5,8). Cord pH at birth in these babies was normal. 
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Two babies had hyperbilirubinemia and five babies had hypoglycaemia. One baby  
hadpolycythemia and required exchange transfusion.  
 
One baby was born at 35+4 weeks with a birth weight of 2390 grams and Apgar of 9  
and 10. This baby developed probable sepsis and convulsions on day 4 of life 
requiring prolonged ICU care and readmission. MRI brain done on day 10 showed  
extensive deep white matter hyperintensities  and restricted diffusion and multiple  
micro and macro haemorrhagic foci and symmetrical hyperintensity and  restricted  
diffusion of parahippocampal gyri and medial temporal lobes with findings suggestive  
of neurotropic viral etiology.  
 
Another baby, born at 35 weeks was initially well with negative blood cultures.  
However, this baby was eventually diagnosed with necrotising enterocolitis (NEC)  
and a patent ductus arteriosus. The baby underwent laparotomy and reanastomosis for  
the NEC as well as thoracotomy for the PDA. This baby was initially discharged well,  
but was readmitted with anastomotic leak, sepsis and shock. The baby succumbed to  
its illness at 2 months and 10 days of life. 
 
One baby was born with anomalies which were not detected antenatally – cleft palate,  
imperforate anus and patent foramen ovale. This baby underwent laparotomy and  
sigmoid loop colostomy and discharged in a stable condition. A few days later baby  
was readmiited with septic shock and guarded prognosis explained to the patients .  
The baby was eventually discharged against medical advice. 
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Table 13 – Mean birth weight in each group 
 Weight in gms 
with standard 
deviation 
p value 
Immediate Delivery arm 2400 +/- 370 
 
 
0.10 
Expectant Management arm 2643 +/- 327 
 
Birth weight in each group -  Mean birth weight in Immediate Group was 2400 gms  
with a standard deviation of 370 gms. The mean birth weight in the Expectant  
Management group is 2643 gms with a standard deviation of 327 gms. This difference  
was not statistically significant. 
Table 14-Postnatal Stay in Hospital– Maternal 
 Immediate 
Delivery Arm 
Expectant 
Management 
p value Total 
Number of women who had 
prolonged stay postnatally 
(>3 days) 
8 (40%) 
 
10 (52.6%) 0.46 18 
(46.15%) 
Reason for prolonged stay 
- Baby‟s sake 
- Maternal 
 
8  
0 
 
10  
0 
  
18 
(46.15%) 
Length of postnatalstay in 
Hospital  
(median) 
5.5 days 6 days   
 
Graph 12– Number of days of Hospitalisation for mother 
 
More patients in the Expectant management arm had prolonged hospital stay (10 vs  
8). All these prolonged admissions were for the babys sake. There were no significant  
maternal complications in either group. 
0
5
10
15
Immediate Delivery Expectant Management
3 days or less
4 days to 1 week
1 - 2 weeks
>2 weeks
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Table 15 - Stay in Hospital– Baby 
 Immediate 
Delivery Arm 
Expectant 
Management 
p value Total 
Number of babies who had prolonged 
stay (>3 days) 
8 (40%) 
 
10 (52.6%) 
 
0.46 17 
(43.5%) 
Length of stay in Hospital (median) 8days 6 days   
NICU admission 
 
- Lethargy, poor feeding 
- Hyperbilirubinemia 
- Depressed at birth 
- Hypoglycaemia  
- Necrotising Enterocolitis, 
Patent DuctusArteriosus 
- Polycythemia for 
exchange transfusion 
- Anomalies (cleft palate, 
imperforate anus) 
- Sepsis 
- Seizures: Suspected Viral 
Encephalitis 
8 
 
1 
1 
1 
0 
 
1 
1 
 
1 
 
1 
 
1 
2 
 
0 
0 
0 
2 
 
0 
0 
 
0 
 
0 
 
0 
 
 
 
 
 
 
 
0.03 
 
 
 
 
 
 
 
10 
(25.6%) 
Readmission 2 0  2 
(5.12%) 
Hospital Bill  (mean with standard 
deviation) 
Rs. 27,078 +/- 
51,357 
Rs. 7,505+/- 
2,866 
0.3  
 
Graph 13 – Hospital Stay for Babies in days 
 
 
 
Eighteen babies needed hospitalisation for more than 3 days, ten babies (52.6%) from  
the Expectant management arm and eight babies (%) from the Immediate Delivery  
0
2
4
6
8
10
12
Immediate Delivery Expectant 
Management
3 days or less
4 days to 1 week
1 - 2 weeks
>2 weeks
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arm. The median duration of stay was six days in the EM arm and eight days in the ID  
arm. 
Stay in NICU (Neonatal Intensive Care) was needed for eight babies in the ID arm  
and only 2 babies in the Expectant Management arm. This difference was statistically  
significant (p value of 0.03). 
 
Two of the Immediate Delivery arm babies required readmission as discussed earlier. 
One of these succumbed to its illness, while the other was discharged at request in a  
critical condition. 
 
The hospital bills (mean) in the Immediate Delivery arm was Rs. 27,078 and in the  
Expectant Management arm was Rs. 7,505. This difference did not show a significant  
statistical difference. However, the babies in the Immediate Delivery arm had a wide  
range of Hospital Bills, from Rs. 3,985 to a maximum of Rs. 2,03,284. The babies in  
the Expectant management arm had bills ranging from Rs. 4,105 to Rs. 13,062 at  
maximum. 
Graph 14 – Hospital Bill for Babies in each arm
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DISCUSSION 
 
Our study screened 157 patients with preterm prelabour rupture of membranes for  
 
eligibility, and 39 patients were recruited into the trial. Of these, 20 patients were  
 
randomised to the Immediate Delivery arm and 19 patients were randomised to the  
 
Expectant Management arm. 
 
Baseline characteristics were similar in both groups. Ninetypercent of patients in the  
 
Immediate Delivery arm and seventy three percent of patients in the Expectant  
 
management arm were in the age group of 18 – 30 years, the rest were above the age  
 
of 30 years. There were no patients over 35 years of age in either arm. Most of our  
 
patients used LPG as a means of fuel and were in the middle socioeconomic class.  
 
Sixty percent of patients in both groups were college educated and had jobs in a  
 
professional capacity, while the rest worked as skilled/ unskilled labour.  
 
 
Seventy five percent of patients in the Immediate Delivery arm and about fifty eight  
 
percent of patients in the Expectant Management arm were primigravidas.  The rest  
 
were multiparous. 
 
 
One patient had a previous Caesarean delivery, one patient was anemic requiring  
  
blood transfusion antenatally, and three in each arm had gestational diabetes. 
 
One patient had diamniotic dichorionic twins. She was a 29 year old primigravida who  
 
presented to us at 34+6 weeks of gestation with leaking per vaginum which was  
 
confirmed on speculum examination. Ultrasound done ruled out selective growth  
 
restriction or growth discordancy. Leading twin was in vertex presentation. She  
 
agreed to be part of the trial, was discharged and managed on an outpatient basis twice  
84 
 
a week. She presented in spontaneous labour ten days after recruitment. Labour was  
 
augmented, and she delivered vaginally at 36+3 weeks, two healthy babies weighing  
 
2770gms and 2280 gms each. Post natal period was uneventful for both mother and  
 
babies. 
 
 
The mean gestational age at rupture of membranes was 35+4 weeks in the Immediate  
 
Delivery arm and 35+2 weeks in the Expectant Management arm. The mean  
 
gestational age at recruitment was 35+4 weeks in the Immediate Delivery arm and  
 
35+1 weeks in the Expectant Management arm. One baby in the Immediate Delivery  
 
arm was breech, the rest were cephalic at presentation. Ninety percent of patients in  
 
the Immediate delivery arm were diagnosed by per speculum examination, while 84.2  
 
percent of patients in the Expectant Management arm were diagnosed by a definite  
 
history of leaking per vaginum. All patients received either oral or intravenous 
 
antibiotics. 
 
 
Primary outcome looked at was neonatal sepsis. There were two patients in the  
 
Immediate delivery arm whose babies developed neonatal sepsis, in comparison to 
 
none in the Expectant Management arm. One baby had suspected late onset sepsis , 
 
not related to  events during intrapartum period  or delivery. Even so, this difference  
 
was not statistically significant. Other studies also did not find a statistically  
 
significant difference in neonatal sepsis when patients were delivered immediately or 
 
after expectant management in PPROM. 
 
 
Nineteen of twenty patients in the Immediate Delivery arm had induction of labour.  
 
One patient underwent LSCS as she developed fetal distress and the baby was breech. 
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Of the Nineteen patients in the Expectant Management arm, we were able to continue 
 
five pregnancies to term, at which time they were induced. The maximum time gained  
 
was 33 days and 50 minutes. Nine patients went into spontaneous labour before 37  
 
weeks. In five patients , expectant management had to be terminated due to  
 
chorioamnionitis, decreased fetal movements or ongoing leaking. 
 
 
The mean time gained in utero in the Expectant Management group was 18 hrs and 29  
 
minutes with a standard deviation of 29 hours and 51 minutes, compared to the  
 
Immediate Delivery arm where mean randomisation to delivery interval was 12 hours  
 
20 minutes with a standard deviation of 7 hours 30 mins. This difference was statistically  
 
significant (p value 0.04). 
 
 
Eleven patients were managed as inpatient up till delivery. Eight patients (42%) were  
 
initially managed as inpatient and then discharged at discretion of senior consultant.  
 
They were then managed on an outpatient basis till time of delivery. This included a  
 
mother with diamniotic dichorionic twins. There was no difference in maternal/  
 
neonatal outcomes with either modality of management. There have been two  
 
randomised trials(79,80) which studied home versus hospital care in patients with  
 
PPROM. A Cochrane metaanalysis(75)found no difference in maternal or neonatal  
 
outcomes with either modality of care, but the studies were not adequately powered to  
 
show a significant statistical difference. 
 
 
One patient developed chorioamnionitis in the Expectant Management group, and  
 
Labour had to be induced for the same. No patients in the Immediate Management  
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group developed chorioamnionitis after randomisation. This difference was not  
 
statistically significant. The PPROMEXIL trial found that immediate delivery  
 
decreased the risk of chorioamnionitis (22% in the immediate delivery group versus  
 
32% in the expectant management group) . However this was not statistically  
 
significant (p value of 0.4). The PPROMT trial also found that women managed  
 
expectantly had a higher incidence of intrapartum fever, however, this difference was  
 
not statistically significant (p value 0.4). These trials had larger numbers, 532 in the  
 
PPROMEXIL trial and 1,835 in the PPROMT trial. 
 
 
Seventy five percent of women in the Immediate Delivery arm had normal  
 
vaginal deliveries, compared with sixty eight percent in the Expectant Management  
 
arm. Twenty five percent of women in the Immediate Delivery arm underwent LSCS/  
 
Instrumental delivery compared with thirty one percent in the Expectant Management  
 
group. The difference between both groups with respect to mode of delivery was not  
 
statistically significant.Our sample size was small, hence results need to be  
 
interpreted with caution. Larger studies like the PPROMT trial found a significantly  
 
higher rate of LSCS in their Immediate Delivery arm compared to  
 
Expectant Management (p value 0.0001). However, other trials ( PROMEXIL and  
 
TERMPROM) did not demonstrate this difference. 
 
 
None of our patients in either arm had antepartum haemorrhage or cord prolapse. In  
 
the PPROMT trial, authors found a significantly higher rate of ante/intrapartum  
 
haemorrhage in the Expectant Management arm, but no difference in the rate of cord  
 
prolapse which occurred<1% of the time in both arms. 
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Neonatal outcomes 
 
 
Hypoglycaemia was found to be equal in both groups. There were two babies with  
 
hyperbilirubinemia in the Immediate Delivery group, and none in the Expectant  
 
Management group.The PPROMEXIL study found a statistically significant higher  
 
rate of both these complications in their Immediate Delivery arm as compared to the  
 
Expectant Management arm. 
 
 
The number of babies who required prolonged stay (>3 days) was actually higher in  
 
the Expectant Management group than the Immediate Delivery group (10 babies  
 
versus 8 babies). However, more babies in the Immediate delivery arm required  
 
intensive care, had more morbidity and ultimately higher hospital bills than their  
 
counterparts in the Expectant Management arm. Despite our small numbers,we were  
 
able to demonstrate a statistically significant difference in the rates of neonatal ICU  
 
admissions in the Immediate Delivery arm compared to the Expectant Management  
 
arm (8 versus 2 babies, p value of 0.03).   
 
 
The cost of stay for the babies post natally was much higher in the Immediate  
 
Delivery group with costs ranging from Rs. 3,985 to Rs. 2,03,284 with a mean of Rs.  
 
27,078. By contrast the babies in the Expectant Management arm had bills ranging  
 
from 4,105 to a maximum of 13,062 with a mean of Rs. 7,505.Although the mean  
cost of hospital stay in immediate delivery group is more than thrice in the expectant  
management group, this was not found to be statistically significant . This could be  
explained by the small sample size of our study 
. 
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A major drawback of our study is that we were unable to obtain a larger sample size.  
 
This was mostly due to patients that were excluded due to elevated C-RP and WBC  
 
counts. Other similar trials such as PPROMEXIL and PPROMT did not use specific  
 
cut offs of CRP and counts for excluding patients from recruitment, whereas we used  
 
specific cut offs for the same, based on our hospital policy. The cut offs we used were  
 
a CRP of 5mg/L and 15,000 cells/mm3 for C-RP and WBC counts respectively. 
 
Looking at the meta analysis conducted by Van der Laar et al (55), the five studies  
 
included used a cut off ranging from >12mg/L to >40mg/L. Reported Sensitivities for  
 
a cut off of >12 mg/L for clinical chorioamnionitis and histological chorioamnionitis  
 
were100% and 88% respectively.  Specificities for clinical chorioamnionitis ranged  
 
from 55% at a cut off of 20 mg/L to 98% at a cut off of >20mg/L. For histological  
 
chorioamnionitis, specificity ranged from 68% at a cut off of >20mg/L to 100% when  
 
this was raised to 40mg/L. 
 
 
We therefore propose to increase our diagnostic threshold for chorioamnionitis to  
 
CRP levels of 12 mg/L and above, as this will increase our yield of cases. There is a  
 
theoretical risk of missing a few cases of chorioamnionitis, but given the above  
 
evidence, this is unlikely. 
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CONCLUSIONS 
 
 
In pregnant women presenting with Preterm Prelabour Rupture of Membranes 
 
between 34 and 36+6 weeks, the risk of Neonatal sepsis does not increase with  
 
Expectant Management upto 37 weeks compared to Immediate Delivery in carefully  
 
selected patients. Maternal morbidity/ mortality is not affected by either Immediate  
 
Delivery or Expectant Management. Mode of delivery does not differ with either line  
 
of management. 
 
Immediate delivery may lead to higher rates of admission to Neonatal ICU, greater  
 
morbidity to the baby and higher hospital costs and emotional anxiety for the parents. 
 
Impact of both modalities of treatment on long term neurodevelopmental outcome of  
babies will require study with a larger sample size with long term follow up of infants  
at least upto 5 years of age. 
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LIMITATIONS 
 
The main limitation of this study is that we were unable to reach our sample size,  
 
leaving this study grossly underpowered. However we plan to continue this study, and  
 
ultimately reach target sample size. 
 
Due to inherent study design we were unable to blind either caregiver or patient to  
 
arm of recruitment. 
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GLOSSARY OF ACRONYMS 
 
PPROM – Preterm Prelabour Rupture of Membranes 
 
CRP – C Reactive Protein 
 
NICU – Neonatal Intensive Care Unit 
 
 UTI – Urinary Tract Infection 
 VSD – Ventricular septal defect 
 END – Early Neonatal Death 
SROC - Summary Receiver Operating Characteristic 
 
ESBL E. Coli – Extended Spectrum Beta Lactamase producing E. Coli 
 
LSCS – Lower Segment Caesarean  
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ANNEXURE 
PROFORMA PPROM 
Date: 
 
    
DEMOGRAPHIC DATA 
   
1. Name  ________________________________ 
2. Allocation 
Number 
    3. Hospital Number 
   
    4. Age (in years) 
   
    5.BMI 
   
    6.Socio economic status 1.Wood 2.Kerosene 3.LPG 
    7. Occupation 1. Unskilled worker 2. Skilled labour 3. Professional 
    
OBSTETRIC DATA 
   
    8.Obstetric score 1.parity-0 2.para-1 3.para-2 
    9. Gestational age in weeks 
   
    10. Date of rupture of membranes 
   
    11. Time of  of rupture of membranes 
   
    12. Mode of diagnosis 1. Definite History 2. Speculum exam 3. ELISA test 
    13. Gestation at rupture of membranes 
   
    14. Azithro/ Flagyl received (If no, skip to 
Question 18) 1. Yes 2. No 
 
    15. Course of A/F completed (If yes, skip to 
Question 18) 1. Yes 2. No 
 
    16. Number of doses of A received 
   17. Number of doses of F received 
   
    18. Steroids received 1. Yes 2. Yes, partly 3. No 
    19. Presentation of baby 1. Cephalic 2. Breech 
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    20. Maternal Risk factors 1. PIH 2. GDM 3. Obese 
    
21. Arm into which recruited 
1. Immediate 
delivery 
2. Expectant 
Management 
 
    
    22. Duration of antenatal hospitalisation of mother 
in days 
   
    23. Duration from randomisation to delivery in 
hours 
   24. Duration from randomisation to delivery in 
weeks 
   
    
    
DELIVERY 
   25. If expectant management- Indication of 
delivery 
1. 37 completed 
weeks 2.Chorioamnionitis 3. Fetal Distress 
    26. Chorioamnionitis after recruitment 1. Yes, intrapartum 2. Yes,  before delivery 3. No 
    27. Mode of delivery 1.  SVD 2. Instrument 3. LSCS 
    
    
28. Indication of LSCS 1. Breech 2. NRFS 
3. Dysfunctional 
labour 
    
    29. Duration of labour  
   
    30. Number of PVs 
   
    31. Number of doses of Ampicillin received 
   
    32. PPH 1. Atonic 2. Traumatic 3. No PPH 
    
    
POSTNATAL COURSE 
   33. Duration of Postnatal hospitalisation of mother 
in days 
   
    34. If more than 3 days, reason for prolonged stay 1. Babys sake 2. Maternal fever 
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35. If maternal fever, focus of infection 1. Endometritis 2.  UTI 3. Sepsis 
    36. Admission to ICU for mother 1. Yes 2. No 
 
    NEONATAL OUTCOMES 
   
    37. Gestational age at delivery 
   
    38. Birthweight in grams 
   
    39. Neonatal sepsis 1. Culture Proven 2. Probable sepsis 3. No sepsis 
    40. Need for resuscitation 1. Yes 2. No 
 
    41. Apgar score at 0 and 5 mins 
   
    42. Cord pH 
   
    43. Pneumonia 1. Yes 2. No 
 
    44. MAS 1. Yes 2. No 
 
    45. RDS 1. Yes 2. No 
 
    47. Necrotizing enterocolitis 1. Yes 2. No 
 
    48. Hypoglycaemia 1. Yes 2. No 
 
    49. Hyperbilirubinemia 1. Yes 2. No 
 
    50. Convulsions 1. Yes 2. No 
 
    51. Need for ICU Care 1. Yes 2. No 
 
    
    52. Duration of ICU care in days 
   
    55. Duration of hospital stay in days 
   
    56. Cost of Hospital Stay for baby 
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Informed Consent form to participate in a research study 
 
Study Title: PPROM  
 
Study Number: 
 
Subject‟s Initials: _________ Subject‟s Name: ________ 
 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
 
(i) I confirm that I have read and understood the information sheet dated _________ 
for the above study and have had the opportunity to ask questions. [    ] 
 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or 
legal rights being affected. [    ] 
 
(iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor‟s 
behalf, the Ethics Committee and the regulatory authorities will not need my 
permission to look at my health records both in respect of the current study and any 
further research that may be conducted in relation to it, even if I withdraw from the 
trial. I agree to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published. [    ] 
 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [    ] 
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(v) I agree to take part in the above study. [    ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory‟s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator‟s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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PPROM STUDY INFORMATION SHEET 
At some point before you complete 9 months of pregnancy, there is a possibility that 
there may be premature leakage of water from the bag surrounding the baby during 
pregnancy.  
In the scenario, we will try to continue your pregnancy for as long as possible. The 
benefits to your baby of staying in the uterus are many. Early delivery could sometimes 
lead to breathing problems, mental and developmental problems in the future, feeding 
problems. All these may occur as the baby has not grown fully and is as yet immature.  
On the other hand, there are some small and unusual risks of continuing pregnancy ,once 
the bag has broken . This includes infection for yourself or your baby, premature 
separation of the placenta that nourishes the baby in the womb and rarely, the umbilical 
cord coming out of the vagina.  
At the present time, the protocol that is followed is that, arrangements are made for the 
delivery of the premature baby either by Caesarian or normal delivery, depending on the 
associated complications. 
 A study done in our department showed that most of the babies born out of premature 
prelabour rupture of membranes are born beyond 8 and a half months of pregnancy. 
However, there is evidence to prove that prolonging pregnancy upto 9 months may have 
considerable long and short term benefits to your baby- less jaundice, less chances of ICU 
admission. There is greater opportunity for development and maturity of organs for 
example the brain and lungs of the baby. 
We invite you to be part of a study, where we will compare between two different types 
of treatment.  One treatment is immediate delivery at 34 weeks. The second is trying to 
prolong your pregnancy for as long as possible till 9 months (37 weeks), and then 
delivery of the baby. If you receive the second treatment option, a close watch will be 
kept on you and your baby for any complications like infection or bleeding. You might 
require hospitalisation at this time. If you need prolonged admission you can be 
discharged and evaluated in the outpatient clinic which you will need to visit twice a 
week. You must keep a close watch on your babys fetal movements. In case of fever, 
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excess leaking per vaginum, bleeding per vaginum, foul smelling discharge per vaginum, 
abdominal pain, decreased fetal movements you must inform your doctor immediately. 
You can contact one of the numbers listed below, or immediately come to the CMC 
Labour Room where you will be evaluated. If complications arise, you will be delivered 
immediately.  If not, the process of labour will be initiated at 37 weeks. 
 If you fall into the” waiting group”, you may have the benefit of not delivering 
prematurely. There will be no increased risk by being part of this study. However, for 
some reason if you do not choose to be part of this study you will have no disadvantage. 
You always have the option of withdrawing from the study without your medical care 
being affected. 
 
In case of any queries, kindly contact 
Dr. Deepti Pinto,    OG IV        Mob. 9626776226        Tel. No.  0416 2286185 
Dr. Manisha, OG IV                   Mob. 9787892640        Tel. No.  0416 2286185 
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SPSS DATA ENTRY VARIABLES 
 
 
name hospital no age BMI socioeconimic_status occupation obstetric_score 
mode_of_diagnosis gestation_at_ROM oral_antibiotics_received 
course_oral_antib_completed steroids_given fetal_presentation maternal_risk_factors 
recriutment_arm duration_antenatal_hosp_days duration_randomisation_delivery_hrs 
duration_randomisation_delivery_weeks duration_randomisation_delivery_months 
ind_of_delivery_if_expectant_arm mode_of_delivery ind_for_lscs duration_labor_hrs 
no_of_pv no_of_ampi_doses pph postnatal_stay_hospi_days reason_long_hospi_stay 
cause_maternal_fever mother_sicu_admission baby_delivered_gest_age birth_wt_gm 
neonatal_sepsis need_for_resuscitation apgar cord_ph neonatal_complication 
NICU_admission days_NICU_stay days_hospital_stay readmission_mother 
neonatal_bill hyperbilirubinemia chorioamnionitis gest_age_at_recruitment 
gest_age_recruit twins 
 
durga                985461f  22 3 3 3 1 2 35.6 2
 3 2 2 3 1 1 2.52 0.00 0.00 4 3 2
 6.30 1 1 3 3 1 4 2 35.6 2080 1 1
 5.80 2 8 1 9 9 2 12780.0 2 2
 35.6 2 2 
rubini               993076f  26 3 3 3 1 2 35.5 1
 2 2 1 3 2 1 30.20 0.00 0.00 2 3 4
 15.50 3 8 3 3 1 4 2 35.6 2420 3 2
 9.10 3 8 2 0 3 2 4670.0 2 2 35.0 2
 2 
rajkumari            894911d  33 3 3 2 3 3 35.5 1
 2 2 1 3 1 1 2.48 0.00 0.00 4 1 5
 6.30 5 3 3 24 1 4 2 36.0 2390 3 2
 9.10 3 5 1 0 28 1 203284.0 2 2
 35.5 2 2 
zehra fatima         383799f  22 2 3 3 3 2 34.3 1
 1 2 1 3 2 3 509.42 0.00 0.00 1 1 5
 6.42 1 2 3 3 1 4 2 37.4 3465 3 2
 9.10 3 8 2 0 3 2 5285.0 2 2 34.3 1
 2 
revathi              743668d  29 2 2 1 4 2 35.3 2
 3 2 1 3 1 2 7.22 0.00 0.00 4 1 5
 7.22 1 1 3 2 1 4 2 35.3 2350 3 2
 9.10 3 8 2 0 2 2 5280.0 2 2 35.3 2
 2 
shaheeda parvee      332599g  30 3 3 3 1 2 35.2 1
 2 2 1 2 2 1 22.05 0.00 0.00 5 1 5
 6.20 1 2 3 7 1 4 2 35.3 2680 3 2
 9.10 3 5 1 6 7 2 12830.0 2 2
 35.2 2 2 
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mythili              424509g  31 2 3 3 1 2 36.1 1
 2 2 1 3 2 1 23.51 0.00 0.00 4 2 5
 6.00 1 1 3 5 1 4 2 36.2 2370 3 2
 9.10 3 8 2 5 6 2 5640.0 2 2 36.1 3
 2 
umma salma           308301g  19 2 3 2 1 2 36.5 2
 3 2 1 3 1 1 4.00 0.00 0.00 4 1 5
 3.52 1 1 3 3 1 4 2 36.6 3000 3 2
 9.10 3 8 2 0 3 2 4865.0 2 2 36.5 3
 2 
esther rani          996577f  27 4 3 3 2 2 34.3 1
 1 2 1 4 2 1 3.32 0.00 0.00 4 3 2
 3.22 1 1 3 5 1 4 2 34.3 2400 3 2
 9.10 3 8 2 0 4 2 5685.0 2 2 34.3 1
 2 
aisha                265014f  25 4 3 3 2 2 35.4 1
 2 2 1 3 1 1 13.08 0.00 0.00 4 1 5
 11.15 2 2 3 21 1 4 2 35.6 2220 2 2
 9.10 3 6 1 21 22 2 62980.0 2 2
 35.5 2 2 
sandhya              335369f  29 4 3 3 2 2 34.6 1
 1 2 1 5 2 12 259.15 0.00 0.00 4 1 5
 6.00 2 2 3 6 1 4 2 36.3 2780 3 2
 9.10 3 8 2 0 6 2 9190.0 2 2 34.6 1
 1 
chitra               727666f  24 4 3 1 1 2 35.4 1
 2 2 1 2 1 1 14.12 0.00 0.00 4 2 5
 8.42 3 2 3 3 1 4 2 35.5 2170 3 2
 9.10 3 8 2 0 3 2 5234.0 2 2 35.4 2
 2 
soundarya            319950g  22 4 3 3 1 2 35.5 2
 3 2 1 3 1 1 28.53 0.00 0.00 4 3 4
 26.38 5 4 3 6 2 4 2 35.6 2420 3 2
 9.10 3 5 2 0 3 2 9360.0 2 2 35.5 2
 2 
hina afreen          334819g  25 3 3 3 1 2 36.3 1
 1 2 1 3 2 5 122.23 0.00 0.00 1 1 5
 8.00 2 4 3 2 1 4 2 37.1 2685 3 2
 9.10 3 8 2 0 2 2 4105.0 2 2 36.3 3
 2 
priyadarshini        084542f  28 3 3 3 2 2 36.5 1
 2 2 1 2 1 1 11.30 0.00 0.00 4 1 5
 5.50 4 2 3 3 1 4 2 35.2 2005 3 2
 8.90 3 5 2 0 3 2 12585.0 2 2
 35.1 2 2 
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preethi              352895g  24 3 3 3 1 2 35.1 1
 2 2 1 3 2 3 74.10 0.00 0.00 5 1 5
 5.25 3 1 3 4 1 4 2 35.4 2510 3 2
 9.10 3 8 2 0 4 2 6465.0 2 2 35.1 2
 2 
chamundeswari        238031g  34 3 3 3 1 2 36.2 1
 2 2 1 2 2 2 44.38 0.00 0.00 5 1 5
 4.38 1 5 3 4 1 4 2 36.4 2500 3 2
 9.10 3 5 2 0 5 2 13062.0 2 2
 36.2 3 2 
madhumathy           343979g  29 3 3 3 1 2 34.5 1
 2 2 1 3 1 1 8.55 0.00 0.00 4 1 5
 8.40 1 1 3 5 1 4 2 34.5 2700 3 2
 9.10 3 8 1 5 6 2 8060.0 2 2 34.5 1
 2 
aswini               977659f  23 2 3 3 1 2 34.6 1
 2 2 1 3 1 1 10.51 0.00 0.00 4 1 5
 10.51 2 2 3 3 1 4 2 35.0 1680 3 2
 9.10 3 4 1 19 20 2 134440.0 2 2
 34.6 1 2 
preeti               984904f  25 3 3 3 1 2 36.3 1
 2 2 1 3 2 1 34.30 0.00 0.00 5 1 5
 4.25 1 1 3 2 1 4 2 36.5 2330 3 2
 9.10 3 8 2 0 2 2 4192.0 2 2 36.3 3
 2 
bhuvaneswari         458540g  26 3 3 3 1 3 36.4 1
 2 2 1 2 1 1 5.41 0.00 0.00 4 2 5
 5.41 2 1 1 4 1 4 2 36.5 2630 3 2
 9.10 3 5 1 4 5 2 6820.0 2 2 36.4 3
 2 
lavanya              304904f  28 3 2 1 2 2 34.6 1
 1 2 1 3 2 0 297.49 0.00 0.00 4 1 5
 5.40 1 1 3 3 1 4 2 36.5 2900 3 2
 9.10 3 5 2 0 3 2 5432.0 2 2 34.6 1
 2 
subashini            502067g  21 2 3 3 1 2 35.0 1
 2 2 1 3 1 1 3.15 0.00 0.00 4 1 5
 3.00 1 1 3 3 1 4 2 35.0 2620 3 2
 9.10 3 8 2 0 3 2 5285.0 2 2 35.0 2
 2 
nalini               338698g  32 3 3 2 1 2 34.0 1
 2 2 1 3 2 1 24.10 0.00 0.00 4 3 2
 8.10 3 1 3 3 1 4 2 34.4 2080 3 2
 9.10 3 5 1 7 8 2 10435.0 2 2
 34.2 1 2 
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naimunnisa           100700d  30 4 3 2 2 2 35.3 1
 2 2 1 3 2 2 139.00 0.00 0.00 4 1 5
 7.10 2 1 3 3 1 4 2 36.1 2580 3 2
 9.10 3 8 2 0 3 2 5285.0 2 2 35.3 2
 2 
najum kousar         507076g  22 2 3 3 1 2 36.3 2
 3 2 1 3 1 1 22.15 0.00 0.00 5 1 5
 13.10 2 2 3 2 1 4 2 36.5 2860 3 2
 9.10 3 8 2 0 2 2 3985.0 2 2 36.3 3
 2 
anupriya             507100g  23 4 2 2 1 2 36.5 2
 3 2 1 3 1 1 10.39 0.00 0.00 5 1 5
 10.10 2 2 3 3 1 4 2 36.5 3100 3 2
 9.10 3 8 2 0 3 2 6020.0 2 2 36.5 3
 2 
suriyakala           209385f  32 4 3 3 2 1 35.3 1
 1 2 1 3 2 2 389.42 0.00 0.00 1 1 5
 5.00 2 1 3 4 1 4 2 37.4 2850 3 2
 9.10 3 5 2 0 4 2 7897.0 2 2 35.3 2
 2 
neelema              883430d  31 4 3 3 2 2 35.3 1
 2 2 1 3 1 1 22.21 0.00 0.00 4 2 5
 9.06 5 2 3 7 1 4 2 35.5 1870 3 1
 5.80 3 8 1 7 8 2 11660.0 2 2
 35.5 2 2 
manjula              507958g  33 3 3 2 1 2 35.2 1
 1 2 1 3 2 4 163.00 0.00 0.00 4 2 5
 10.00 3 2 3 7 1 4 2 36.3 2340 3 2
 9.10 3 8 2 0 7 2 10545.0 2 2
 35.2 2 2 
gayatri              428416g  18 3 2 2 1 2 34.3 1
 2 2 1 3 1 1 21.47 0.00 0.00 5 1 5
 8.20 4 1 3 2 1 4 2 34.4 2250 3 2
 9.10 3 8 1 5 5 2 9460.0 1 2 34.3 1
 2 
sheerin              941533d  22 3 3 2 2 2 36.0 1
 1 2 1 3 2 2 269.50 0.00 0.00 1 1 5
 5.10 1 1 3 3 1 4 2 37.0 2800 3 2
 9.10 3 8 2 0 3 2 5285.0 2 2 36.0 3
 2 
shabana              513072g  23 4 3 3 1 2 35.3 1
 2 2 1 3 1 1 15.38 0.00 0.00 5 1 5
 11.40 3 2 3 9 1 4 2 35.4 2750 3 2
 9.10 3 8 2 0 3 2 17676.0 1 2
 35.3 2 2 
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kashita              416702g  25 4 3 2 1 1 34.2 1
 1 2 1 2 2 2 205.00 0.00 0.00 4 3 4
 12.30 3 3 3 8 1 4 2 35.4 2440 3 1
 5.90 2 4 2 0 8 2 8275.0 2 2 34.2 1
 2 
abirami              397694g  20 4 3 3 1 2 36.3 1
 2 2 1 3 1 1 12.25 0.00 0.00 5 1 5
 8.25 2 2 3 3 1 4 2 36.3 2290 3 2
 9.10 3 5 2 0 3 2 5285.0 2 2 36.3 3
 2 
jagatheswari         469597g  30 4 3 2 1 2 36.0 1
 2 2 1 3 2 1 27.46 0.00 0.00 2 1 5
 6.25 2 2 3 5 1 4 2 36.1 3060 3 2
 9.10 3 8 2 5 5 2 10620.0 2 1
 36.0 3 2 
ashwini              801247d  28 2 3 3 3 1 34.4 1
 1 2 1 3 2 2 792.15 0.00 0.00 1 1 5
 3.50 1 1 3 3 1 4 2 38.2 3030 3 2
 9.10 3 8 2 0 3 2 7715.0 2 2 34.4 1
 2 
sandhiya             519053g  19 2 3 2 1 2 33.2 1
 2 1 1 3 1 2 2.13 0.00 0.00 5 1 5
 2.13 1 1 3 3 1 4 2 34.0 2190 3 2
 9.10 3 8 2 0 3 2 12195.0 2 2
 34.0 1 2 
farheen              436450g  23 2 3 2 1 2 35.1 1
 2 2 1 3 1 1 23.30 0.00 0.00 5 1 5
 10.34 4 3 3 3 1 4 2 36.3 2440 3 2
 9.10 3 8 2 0 3 2 4320.0 2 2 36.2 3
 2 
 
